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ABSTRACT 
Major depressive disorder (MDD) is a multidimensional psychiatric disease, considered by the 
World Health Organization as one of the leading causes of disability. Despite the importance of this 
disease in modern societies and the large investment of resources already made in its study, the 
processes underlying its pathophysiology remain poorly understood. Several hypotheses have been 
proposed to clarify the neurobiological mechanisms underlying this psychiatric disorder, being the link 
between adult hippocampal neurogenesis and MDD a central topic in the past decades. Previous 
studies have identified AP2γ as a key regulator of adult hippocampal neurogenesis in mice, being 
expressed in a subpopulation of adult transient amplifying progenitors, and acting as a regulator of 
basal progenitors, promoting proliferation and glutamatergic neuronal differentiation. Thus, we wanted 
to further explore the impact of AP2γ in brain neurophysiology and behavior during development and at 
adult stages, dissecting also its mechanisms both in healthy and depressive states. With this study, we 
were able to understand the impact of AP2γ in post-natal development and during juvenile age, through 
the AP2γ constitutive knockout (KO) model. In the developmental milestones assessment we did not 
find any major impairment in the behavioral performance of AP2γ KO mice, since all parameters 
analyzed, including the ones where we found differences, were within the typical range for appearance 
of the developmental milestones. However, in the juvenile behavior assessment and in the hippocampal 
glutamatergic neurogenesis process, impairments were found, since AP2γ KO mice showed anxious-like 
behavior and decreased proliferation of immature neurons. To study the impact of modulating the 
transcription factor AP2γ in depression we exposed both constitutive and conditional KO animal models 
to a chronic stress protocol, which efficiently induced core depressive-like symptoms. Through the 
conditional AP2γ KO mice, we were able to elucidate the impact of deleting AP2γ on behavior and 
neurogenesis in depressive-like conditions specifically in adult age, without the interference of potential 
functions of the gene during early development that may appear in the constitutive AP2γ model. 
Through a multidimensional behavioral analysis, we observed that both models presented similar 
results in the three most affected behavioral dimensions in depression, namely anxiety, mood and 
cognition. Regarding anxiety and mood no major differences were found between genotypes in both 
animal models. Moreover, AP2γ KO mice presented cognitive deficits in basal conditions, but when 
exposed to chronic mild stress no detrimental effects of deletion of the gene were observed. In this 
work, we also identified, through a broad analysis of the dentate gyrus neurogenic niche, alterations of 
epigenetic regulators in the AP2γ constitutive KO mice after uCMS exposure. The reported results not 
only support the involvement of AP2γ in the transcriptional network that modulates the juvenile and 
adult neurogenic process, but also highlight the potential of this molecule as a future therapeutical tool 
in neuropsychiatric disorders, in which neurogenesis is impaired. 
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RESUMO 
O transtorno depressivo persistente é uma doença psiquiátrica multidimensional, considerada 
pela Organização Mundial de Saúde como uma das principais causas de incapacidade. Apesar da 
importância desta doença na sociedade moderna, e do largo investimento de recursos já feitos no seu 
estudo, os processos subjacentes à sua patofisiologia continuam pouco percebidos. Várias hipóteses 
foram propostas para clarificar os mecanismos neurobiológicos implícitos nesta doença psiquiátrica, 
tendo sido o vínculo entre a neurogénese hipocampal adulta e a depressão um tópico central nas 
décadas passadas. Estudos anteriores identificaram o AP2γ como um regulador chave da neurogénese 
hipocampal adulta em ratinhos, sendo expresso numa subpopulação de células progenitoras de rápida 
amplificação adultas, e atuando como regulador de progenitores basais, promovendo a proliferação e a 
diferenciação neuronal glutamatérgica. Deste modo, propusemos continuar a explorar o impacto do 
AP2γ na neurofisiologia cerebral e no comportamento, durante a fase de desenvolvimento e na idade 
adulta, procurando entender também os seus mecanismos tanto no estado saudável como em 
depressão. Com este trabalho, fomos capazes de entender o impacto do AP2γ no desenvolvimento 
pós-natal e em idade juvenil, a partir do modelo animal de deleção constitutiva do AP2γ. Na avaliação 
dos marcos de desenvolvimento, não encontramos nenhuma alteração no desempenho 
comportamental nos animais com deleção de AP2γ, visto que todos os parâmetros analisados, 
incluindo os que encontramos alguma diferença, se encontravam dentro dos intervalos típicos de 
aparecimento dos marcos de desenvolvimento. Contudo, na avaliação do comportamento juvenil e no 
processo de neurogénese glutamatérgica hipocampal observamos défices, visto que os animais com 
deleção de AP2γ apresentaram comportamento ansioso e uma diminuição da proliferação de 
neurónios imaturos. Para estudar o impacto da modulação do fator de transcrição AP2γ em depressão 
expusemos tanto o modelo animal com deleção constitutiva bem como o modelo animal condicional do 
gene a um protocolo de stress crónico, o qual eficientemente induziu sintomas primários de depressão. 
Através do modelo animal condicional do AP2γ, conseguimos compreender o impacto da deleção do 
AP2γ na modulação do comportamento e neurogénese em condições depressivas especificamente em 
idade adulta, sem interferência das potenciais funções do gene durante o período de desenvolvimento 
dos animais, que poderão surgir no modelo animal constitutivo do AP2γ. Através, de uma análise 
comportamental multidimensional, observamos que ambos os modelos apresentaram resultados 
similares nas dimensões comportamentais mais afetadas na depressão, nomeadamente a ansiedade, 
o humor e a cognição. Relativamente à ansiedade e ao humor não encontramos grandes diferenças 
entre genótipos em ambos os modelos animais. Além disso, os modelos animais de deleção do AP2γ 
apresentaram défices cognitivos em condições basais, mas após exposição ao stress crónico não 
foram observados os efeitos prejudiciais da deleção do gene. Neste trabalho, também identificamos, 
através de uma análise abrangente do nicho neurogénico girus denteado, um reguladores epigenéticos 
alterados no animal constitutivo do AP2γ. Os resultados apresentados não só suportam o envolvimento 
do AP2γ na rede transcripcional responsável pela modulação do processo neurogénico juvenil e adulto, 
como também destacam o potencial desta molécula em abordagens terapêuticas futuras em doenças 
neuropsiquiátricas, nas quais a neurogénese se encontra afetada.  
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1) INTRODUCTION 
 
1.1. Depression 
 
1.1.1. State of the art 
Major depressive disorder (MDD) is considered by the World Health Organization (WHO) as one 
of the world leading causes of disability, since it is estimated that around 350 million people worldwide 
are affected with this psychiatric disorder. It is the most disabling medical condition, in terms of years 
lost due to disability, and it is foreseen that by 2030 depression will be the major contributor to the 
global illness burden (Willner et al. 2013). Patients suffering from this disorder usually display a loss of 
interest for experiencing pleasurable activities (anhedonia), changes in appetite and sleep pattern, 
abnormal sadness states, high levels of anxiety, lack of energy and ultimately suicidal ideation. 
Moreover, rather than low self-esteem, depressive patients present a deeply negative view of the world 
and the future, showing also deficits of attention, interpretation and memory (Mathews and MacLeod 
2005; Willner et al. 2013; Bergstrom and Meacham 2016). 
Despite the importance of this multidimensional psychiatric disease in modern societies and 
the large investment of resources already made to look for efficient treatment, the processes underlying 
its pathophysiology remain poorly understood. It is accepted that this complex disorder involves gene-
environment interactions, but the genetic and environmental subtracts are largely unknown. Even 
though there is little knowledge regarding the real causes for the precipitation of MDD, vulnerability or 
predisposition to develop depression may occur throughout lifetime due to negative environmental 
stimuli. It is recognized that harmful early life experiences, such as inadequate familial relations, 
increase the risk for a depressive episode (Willner et al. 2013; Slavich and Irwin 2014). Also, it is 
consensually accepted that there is a familial predisposition to inherit this disorder through “stress-
provoking” genes passing on across generations and providing vulnerability to develop MDD (Slavich 
and Irwin 2014). However, such genetic transmission pattern, which does not follow the Mendelian 
laws, is highly complex, and even with the evolution of technical means and the human genome 
sequencing, it has not been clarified yet. These scientific difficulties to understand the mechanisms 
underlying depression, can be explained by the multiple neurological systems that are likely involved in 
the etiopathogenesis of depression (Marsden 2013). Due to the lack of knowledge in this scientific field, 
there are still many unmet medical needs to address. 
 
 
4 
Looking for a way to successfully revert and treat major depression, several hypotheses have 
been proposed to clarify the neurobiological mechanisms underlying the onset, maintenance and 
recovery from this psychiatric disorder: the neurochemical and neurotrophin hypotheses; involvement of 
cytoquines and inflammatory agents; glutamate excitotoxicity; altered HPA axis; the phase-shift; and the 
neurogenic hypothesis (Bessa et al. 2009a; Hasler 2010). Depression has a great impact on the central 
nervous system (CNS) inducing structural and neuroplasticity alterations in brain regions such as the 
prefrontal cortex (PFC), the amygdala, the ventral striatum (including the nucleus accumbens), and the 
hippocampus (Pittenger and Duman 2008). Indeed, in the past three decades, a vast number of 
studies have revealed that during a depressive episode, it is possible to observe cell loss and neuronal 
atrophy in the hippocampus, which is a brain area with relevant roles both in adult brain neuroplasticity 
and behavioral control (Pittenger and Duman 2008; Serafini 2012; Mateus-Pinheiro et al. 2013). 
Several mechanisms were proposed to explain this cell loss and neuronal atrophy, among which we 
could find the glucocorticoid and glutamate toxicity for both glia and neurons (Duman 2009; 
Kudryashova 2015), the decreased neurotrophic factors expression (Castren et al. 2007) and  also the 
reduced neuronal plasticity (dendritic arborization atrophy and neurogenesis reduction in the 
hippocampal neurogenic niche) (Bessa et al. 2009a) in animal models of depression. The potential link 
between adult neurogenesis and MDD has drawn some attention in the past decades (WuiMan et al. 
2013). Although being a controversial topic, the so called neurogenic hypothesis of depression, has 
brought different relevant questions that challenge the classical conceptions regarding depression, and 
addresses the neurogenic process as a key pathological player and therapeutical target in stress-related 
disorders (Eisch and Petrik 2012).  
Assuring the implication of adult neurogenesis in depression will support the need to better 
understand the adult hippocampal neurogenic niche not only in physiological but also pathological 
conditions. Such knowledge will possibly lead to additional therapeutical approaches by artificially 
regulating the endogenous neural progenitors pool, in order to sustain hippocampal neurogenesis, and 
counteract the inhibitory effects induced by depression. This goal could be achievable through genetic 
or epigenetic regulation of the adult hippocampal neurogenesis process. For this, research should focus 
in finding key transcriptional factors and epigenetic modulatory molecules that regulate hippocampal 
neurogenesis, and thus present strong therapeutical potential. Altogether, it may be relevant to bring 
new insights on the transcriptional network and the epigenetic mechanisms underlying adult 
neurogenesis in the healthy and “diseased” brain, to fully understand this highly complex 
neurobiological process, and its potential role as a therapeutical solution for depression. 
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1.1.2. Modeling depression in animal models  
 Modeling of human neuropsychiatric disorders, such as depression, in animals is extremely 
challenging given the subjective nature of many key symptoms, the lack of objective tests, and the poor 
knowledge regarding the onset, maintenance and recovery from such diseases (Nestler and Hyman 
2010). Nonetheless, a lot of effort has been made in order to construct animal models and protocols to 
understand the pathophysiology of depression and develop different modulatory drugs with therapeutic 
actions.  
Knowledge of the etiopathogenesis of depression has progressed substantially in the last years, 
in part due to studies in animals models (Patricio et al. 2013). The validity of an animal model for 
formulation of hypotheses and for the development of novel therapeutic strategies encompasses: the 
use of known etiological factors (etiological validity), it must mimic the behavioral and neurological 
symptoms observed in human disease (face validity) and importantly, it must respond to clinically 
effective treatments (predicted validity) (Berton et al. 2012; Patricio et al. 2013). Although selected 
depressive symptoms may be irreproducible in animals, such as suicidal ideation, a number of models 
exhibit considerable construct validity when targeting other clinical phenotypes of depression. One of 
the most important advances in understanding psychiatric disorders, like depression, has been the 
development of mice with altered expression of specific targets, being it a receptor, transporter, enzyme 
or signal transduction molecule (Tecott and Wehner 2001; Cryan and Mombereau 2004). These new 
tools have the potential to verify novel targets for antidepressant activity for which few established 
pharmacological tools exist. Moreover, these genetically altered mice will enable better testing of the 
validity of current molecular theories of depression (Cryan and Mombereau 2004). Although there are a 
large number of mice strains that have been generated with a phenotype that has been interpreted as 
being related to depression or antidepressant action, there are three most recommend mice strains to 
use in a depression study: C57Bl/6J, SV/129 and BALB/c mice (Bergner et al. 2016).  
There are several models of depression described in the literature: chronic unpredictable stress 
(CUS), unpredictable chronic mild stress (uCMS), social stress, early life stress, learned helplessness, fear 
conditioning and olfactory bulbectomy (Duman 2010; Patricio et al. 2013). Despite none of these models 
can fully recapitulate the complexity and heterogeneity of the human disease, they are considered 
robust approaches to study depression. However, the uCMS protocol (Willner et al. 2013), based in the 
principles of the CMS and CUS protocols was proven to be a more robust approach to model the 
human depression at the lab. In this model, after exposure to chronic mild stressors implemented in an 
unpredictable way, stressed animals present depressive-like symptoms such as anhedonia, anxiety and 
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cognitive deficits, showing in this way impairments in all three behavioral dimensions known to be 
affected in humans with depression (Bessa et al. 2009a; Mateus-Pinheiro et al. 2013). Moreover, these 
stressed animals show impaired neuroplasticity, and compromised regulation of the corticosterone 
levels, another well-known molecular phenotypes of depression and other stress-related disorders 
(Mateus-Pinheiro et al. 2013; Patricio et al. 2015). Although the uCMS was first described using a rat 
animal model, this model of depression induction has also been validated in mice (Surget and Belzung 
2009), maintaining its translational value as it induces some core alterations that are similar to those 
observed in depressed patients (Sibille et al. 2009; Nollet et al. 2013). 
In sum, although the currently available rodent models have significant limitations, ranging from 
weak validation to poor predictive power for drug efficacy in human disease, they have been a powerful 
tool to investigate the pathophysiology of depression. Further understanding the mechanisms 
underlying the pathophysiology of depression is of the upmost importance to allow improvement of the 
experimental animal models and lead to more complete and targeted depressive studies. 
     
1.2. Adult neurogenesis in the mammalian brain: genetic and epigenetic 
modulation of the hippocampal neurogenic process 
 
1.2.1. Neurogenesis in the adult mammalian brain 
 The discovery of neurogenesis in the adult mammalian brain, overturned the long-held dogma 
that the adult central nervous system (CNS) was immutable, and had no capacity for generating new 
cells (Altman and Das 1965; Deng et al. 2010). Although the emergence of adult neurogenesis as a 
research field in neuroscience has brought much excitement, there was a lot of reluctance manifested 
towards the first reports in this area (Egeland et al. 2015). Despite the initial skepticism, it is now well 
established that new neurons are continuously generated, differentiated and integrated in the 
preexisting brain neuronal networks (Doetsch et al. 1999; Gage 2002; Deng et al. 2010). Adult 
neurogenesis is not a single isolated event, is thus a complex process, involving a wide range of highly 
regulated steps, starting with the proliferation of neural stem cells (NSCs) that will then divide to give 
rise to transient amplifying progenitors (TAPs) which will be responsible for the rapid expansion of the 
multipotent progenitor cells pool. TAPs will then differentiate in immature cells, committed to a 
neuronal phenotype (neuroblasts), that will undergo morphological and physiological maturation with 
acquisition of neuronal characteristics, and will finally become functionally integrated in the pre-existing 
network (Figure 1) (Balu and Lucki 2009).  
 
 
7 
 
 
 
 
 
 
 
 
In the adult brain there are specific areas where neurogenesis persists throughout life, known 
as neurogenic niches (Urban and Guillemot 2014). Such spatially defined brain regions where 
neurogenesis occurs display the presence of immature NSCs from which new neurons can develop, 
and a permissive microenvironment rich in cell-extrinsic factors needed to favor the generation of new 
cells (Urban and Guillemot 2014). 
Although being a controversial topic, there are two consensual neurogenic brain regions broadly 
recognized in the adult mammal brain: the subependymal zone (SEZ) lining the lateral ventricles and 
the subgranular zone (SGZ) of the hippocampal dentate gyrus (DG) (Figure 2) (Zhao et al. 2008; Balu 
and Lucki 2009; Urban and Guillemot 2014). These two neurogenic niches are largely responsible for 
the formation of distinct types of neurons. In the SEZ the precursor cells are mostly found in the 
temporal walls of the lateral ventricles. Here, newly-born precursor cells generate neuroblasts that 
migrate along the rostral migratory stream (RMS), reaching the olfactory bulb (OB). At the OB, 
neuroblasts differentiate and mature, becoming largely GABAergic granule, and periglomerular 
inhibitory interneurons (Chumley et al. 2007; Belenguer et al. 2016). In the DG, the precursor cell 
population resides throughout the SGZ with specific gradients (Silva et al. 2006). After being formed in 
the SGZ, the newly-born neuronal cells – neuroblasts, become committed to a neuronal lineage and 
migrate into the granular cell layer (GCL), where they fully differentiate into excitatory glutamatergic 
granule neurons (Brill et al. 2009). In addition to these two consensually recognized neurogenic niches, 
Figure 1. Neurogenesis is a process not an isolated event. 
Adult neurogenesis is regulated at many different stages of cell development. Here the term neurogenesis comprises all 
necessary steps, starting with the division of a NSC and resulting in the existence of a functionally fully integrated newborn 
neuron. Interestingly, a high percentage of the newborn neurons die before becoming fully integrated in the network. 
Gliogenesis also happen at a lower percentage in the adult neurogenic niches. Newborn glial cells are thought to be 
generated from the same progenitor cells that give rise to neurons. Adapted from (Kempermann, 2011). 
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some research groups have presented evidence that neurogenesis can occur in other brain regions like 
the striatum (Luzzati et al. 2006; Inta et al. 2016), the cortex (Kodama et al. 2004; Ohira et al. 2010), 
the amygdala (Goncalves et al. 2008) and the hypothalamus (Fowler et al. 2002; Kokoeva et al. 2005). 
However, these results are quite controversial and further studies are needed to ashore that these 
neurogenic niches have indeed NSCs and a permissive microenvironment to allow the formation of new 
functional neurons. 
 Despite the increasingly intense research, a great number of questions regarding the adult 
neurogenesis process remain to be answered and understood. It is unquestionably recognized that in 
the healthy adult mammalian brain new neurons can be generated, but its functional relevance remains 
to be fully comprehended. While this singularity is confined to a few privileged brain regions, the 
generation of new neurons in the post-natal brain represents a new dimension of plasticity, impacting 
both directly and indirectly on neuronal remodeling and repair. This promising therapeutical target, for a 
wide range of neuropathological contexts, is one of the main reasons why this field is so interesting. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The two neurogenic niches in the adult mammalian brain. 
Two regions of the adult mammalian brain are broadly recognized to be neurogenic under physiological conditions: (SEZ) 
Precursor cells residing in the walls of the lateral ventricles give rise to interneurons that integrate into the olfactory bulb. 
(SGZ) Neurogenesis in the adult hippocampal dentate gyrus generates new excitatory granule cells throughout life. These 
two processes of adult neurogenesis originate from different precursor cell populations, are independently regulated, and 
serve entirely different regions (Kempermann 2011). Abbreviations: CSF - Cerebral spinal fluid. 
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In the healthy brain, the functional importance of adult neurogenesis has been differently 
associated between the two most commonly accepted neurogenic niches. While the SEZ has already 
been associated with olfactory discrimination (Moreno et al. 2009), hippocampal neurogenesis has 
been related with memory, learning, pattern separation and even emotional behavior (Deng et al. 
2010). Somehow the functional importance of adult neurogenesis in the SEZ has not yet been highly 
associated with a wide range of neuropathological conditions. However, there are already some studies 
reporting impairments in this specific neurogenic niche in neurodegenerative conditions, such as 
Alzheimer’s disease (AD) (Curtis et al. 2007). Abnormal alterations in the hippocampal neurogenesis 
have been associated to a variety of pathologies, including neuropsychiatric disorders (Chambers 2013; 
Schoenfeld and Cameron 2015; Kang et al. 2016). Numerous research groups are trying to unveil the 
biological mechanisms underlying these disorders, also allowing us to better understand the process of 
hippocampal neurogenesis. 
 
1.2.2. The hippocampal neurogenic niche: an overview of the adult hippocampal 
neurogenic process 
 In the adult mammalian brain, hippocampal neurogenesis produces new excitatory granule 
cells in the DG, in a highly regulated and complex process, that can be divided into four major steps: (1) 
the precursor cell phase, that comprises the proliferation of NSCs and the expansion of the precursor 
cell pool; (2) the early survival phase, during which the majority of the newborn cells are eliminated 
even before they make synaptic contacts with reach their target regions; (3) the post-mitotic maturation 
phase where it is possible to observe the functional integration of newly-born neurons into pre-
established neural networks; and (4) the late survival phase, in which the establishment of new 
synapses with pre-existing surrounding cells is completed and a final selection occurs based on the 
newborn neurons functionality (Kempermann et al. 2004; Balu and Lucki 2009; Nicola et al. 2015) 
(Figure 3). Interestingly, this post-natal neurogenesis mimics the embryonic neurogenic process, but 
differing in the fact that, in the adult brain, the newborn neurons are generated in an already mature 
microenvironment, and as such they have to integrate the pre-existing neuronal circuits.   
The SGZ of the hippocampal DG, contains a heterogeneous progenitor cell population with 
distinct degrees of stemness, that can be identified by a specific group of molecules, expressed by each 
cell type. These different molecules (presented in Figure 2) are strongly associated with the different 
phases of the adult hippocampal neurogenesis process. The type-1 progenitor cells, also known as 
quiescent neural progenitor (QNPs) cells and NSCs, are believed to be multipotent stem cells with 
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unlimited self-renewal capacities. These cells have astroglial and radial glia-like properties that can be 
further distinguishable into two classes: horizontal astrocytes (hA) and radial astrocytes (rA). The 
asymmetrical division of type-1 progenitor cells give rise to two consecutive stages of transient 
amplifying neural progenitor cells (ANPs): type-2a progenitor cells, followed by the type-2b progenitor 
cells. The main differences between these ANPs are their proliferative potential and its increasing stage 
of differentiation. It is in this phase of the neurogenic process that emerges a neuronal or non-neuronal 
lineage commitment, being for this reason, a decisive checkpoint in the determination of the neural 
progenitors’ cell-fate. Different reports have demonstrated that these ANPs are highly mitotic cells with 
symmetric divisions (Doetsch et al. 1999; Encinas et al. 2006). But at some point they exit the cell 
cycle and enter into a postmitotic stage in which they give rise to neuroblasts (also known as type-3 
progenitor cells) and establish network connections with the pre-existing neural circuits (Kempermann 
et al. 2004). These last cells are intermediate progenitors in the formation of new granule neurons, 
expressing the microtubule associated protein doublecortin (DCX) that will be crucial, to the maturation 
and migration of the newly-born cells into its final location in the GCL (Balu and Lucki 2009; Nicola et 
al. 2015). Here, they fully mature and integrate the pre-existing neural-circuits, elongating their axons 
and establishing new functional connections. It is currently assumed that the interval that takes to a 
newly-born cell to become a fully maturated and integrated granular neuron is typically referred to be 
approximately 4 to 5 weeks (Zhao et al. 2006; Zhao et al. 2008). Nevertheless, there are some authors 
who claim that the complete period of adult neurogenesis can take as much as 7 weeks, as this is the 
time needed by the new neurons to be electrophysiologically indistinguishable from the remaining pre-
existing neuronal cells (Ambrogini et al. 2004). 
 Breaking down adult hippocampal neurogenesis in these few accessible phases opens up a 
new view on how neuronal development occurs under the condition of the adult hippocampus 
(Kempermann et al. 2004). The hippocampal neurogenic niche turns out to be a fined tuned complex 
process with many developmental steps sensitive to different regulatory influences. These regulatory 
mechanisms are still to be fully understood, but in the past years, several efforts have been made to 
comprehend the complex transcriptional and epigenetic orchestration of adult hippocampal 
neurogenesis. 
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1.2.3. Transcriptional network underlying hippocampal neurogenesis: a focus on 
the transcription factor activating protein 2 gamma (AP2γ) 
 In the past years, there has been a great effort in the field to understand the transcriptional 
regulators involved in the hippocampal glutamatergic neurogenesis process, both in early 
developmental stages and also during adulthood. Complementing the current knowledge regarding the 
transcriptional network responsible for post-natal neurogenesis is highly relevant, so that new regulatory 
molecules could be used in repair and therapeutical strategies for neurological diseases. During cortical 
development, regulation of glutamatergic neurogenesis is controlled by a set of transcriptional factors 
including Pax6, Ngn2, Tbr2, NeuroD and Tbr1 (Englund et al. 2005). Interestingly, it was found that 
during post-natal glutamatergic neurogenesis, interneurons recapitulate this transcriptional sequence 
(Sox2àPax6àNgn2àTbr2àNeuroDàTbr1) that hallmarks the embryonic glutamatergic neurogenic 
process in the developing cerebral cortex (Brill et al. 2009).  
Transcription factors such as Sox2, Pax6, Tbr2, Ngn2 and NeuroD have already been proved 
not only to participate in this transcriptional sequence, but to have key modulatory actions on the 
Figure 3. Developmental stages in the adult hippocampal neurogenic process. 
Neuronal development in the adult DG encompasses several highly regulated steps. This process begins with the division of neural 
stem cells (NSCs), also known as quiescent neural progenitors (QNPs or type 1 progenitors), giving rise to amplifying neural 
progenitors (ANPs or type 2 progenitors). ANPs start to exhibit the first signs of cell-lineage commitment and eventually exit the 
mitotic phase to become neuroblasts (type 3 progenitors). Then, the neuroblasts will differentiate and migrate towards its final 
destination where they will integrate and maturate into fully mature granular neurons, establishing synapses within the pre-existing 
circuits. Each cell type can be distinctively identified by cellular and neuronal markers, some of which are indicated in the figure. It 
is currently accepted that the entire process of adult glutamatergic neurogenesis takes around 4-7 weeks. Abbreviations: GFAP -
Glial fibrillary acidic protein; DCX - Doublecortin; PSA-NCAM - Polysialylated-neural cell adhesion molecule; NeuN - Neuronal 
Nuclei. 
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glutamatergic neurogenic process. Sox2 transcription factor is also essential for pluripotency of the 
epiblast, embryonic stem cells (ESCs) and reprogrammed induced pluripotent stem cells. Moreover, 
Sox2 is expressed at early stages of CNS development and during post-natal neurogenesis by type 1 
and type 2a cells. Previous studies have already reported that mutations and targeted ablation of this 
transcription factor leads to a reduced number of type 1 cells and decreased proliferation and 
glutamatergic neurogenesis in the SGZ of the hippocampal DG (Favaro et al. 2009). The same output 
was provided by animals with targeted deficiencies in Pax6, which has key modulatory actions in brain 
development and post-natal neurogenesis, being involved in the control of cell proliferation and 
neuronal fate determination (Maekawa et al. 2005). Furthermore, reduced expression of the 
transcription factor Tbr2 in the SGZ of the DG have already been showed to cause impairments in 
glutamatergic neurogenesis, since its highly involved in the coordination and regulation of the TAPs 
(Hodge et al. 2008). Likewise, studies with deletion and overexpression of Ngn2 and NeuroD, which are 
involved in granule neuroblasts production and neuronal fate specification, respectively, revealed the 
key actions of these transcripts in the modulation of the glutamatergic neurogenic process (Gao et al. 
2009; Roybon et al. 2009). 
 Activating protein 2 gamma (AP2γ) is a transcription factor that integrates the transcriptional 
network regulating the glutamatergic neurogenic process, acting as a downstream target for Pax6, and 
being involved in the regulation of basal progenitors determinants, such as, Tbr2 and NeuroD (Figure 
4). Importantly, AP2γ is critical for the specification of glutamatergic neocortical neurons and their 
progenitors (Pinto et al. 2009).  
 The AP2γ gene is part of the AP2 transcription factor family, which in mammals, comprises 5 
members, AP2α, AP2β, AP2γ, AP2δ and AP2ε, all sharing common structural and functional features 
(Bosher et al. 1996; Oulad-Abdelghani et al. 1996; Moser et al. 1997; Zhao et al. 2001; Eckert et al. 
2005). AP2 proteins have a conserved transcriptional activator domain at the amino-terminal end, 
acting as homo- or heterodimers, and their dimerization-binding mechanisms are mediated by a basic 
helix-span-helix motif (Pinto 2008). Furthermore, both dimerization as well as the basic domain are 
essential for DNA-binding. These family of transcription factors was also identified in chicken, Xenopus 
and bony fish (Eckert et al. 2005). The poor similarity between these homologs, their paralogs in 
Drosophila and Caenorhabditis, and the inexistence of AP2 transcription factors in yeast, is suggestive 
of a late emergence of these transcription factors in evolution and its predominance in vertebrate 
species (Eckert et al. 2005). 
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Generally, these AP2 proteins are recognized to be involved in various systems and biological 
processes (such as, cell proliferation, cell adhesion, developmental morphogenesis, tumor progression 
and cell fate determination), through the regulation of a large number of target genes with different 
biological functions (Batsche et al. 1998; Ebert et al. 1998; Maconochie et al. 1999). The different 
functions of these proteins seems to be largely dependent on their interaction partners in the spatially 
and locally defined system where they act. Many proteins are known to physically interact with this 
family of proteins, and therefore are influenced with their presence.  
 Throughout the developmental phases, AP2 family of transcription factors are often co-
expressed, and their proteins seem to have, at least, partially redundant functions. However, different 
phenotypes are obtained with the deletion of a specific AP2 gene, and there is no resembles between 
the mutant of another member of this family (Pinto 2008). For instance, selective loss of AP2α leads to 
severe malfunctions in craniofacial features (both skeletal and epidermal tissue), first appearing at 
embryonic day (E) 9.5, which was supposed to be due to a significant increase in apoptosis of 
migratory neural crest cells at E9 (Schorle et al. 1996). In the knockout (KO) mice for AP2β evident 
kidney abnormalities are found, during the embryonic development. At E16.5 the tubuli and collecting 
ducts undergo cystic transformation due to cell-autonomous apoptosis of renal epithelia (Moser et al. 
1997). Both of these different phenotypes, resulting from the deletion of AP2α and AP2β, are lethal. 
 In mouse, AP2γ (or Tcfap2c or Tfap2c according to the mouse genome informatics database) 
is expressed during developmental stages, both in central and peripheral nervous system, as well in the 
adult mouse forebrain (Pinto et al. 2009). In the developing mouse embryo, expression of AP2γ was 
early detected in all trophoblast cells at day 3.5 (E3.5), and its expression is maintained in all 
trophoblast cell lineages, with higher expression levels laterally and rostrally, following the gradient of 
neurogenesis (Werling and Schorle 2002; Eckert et al. 2005). Expression levels further increase to mid-
neurogenesis (E14) in the progenitor layer, declining from then on (Eckert et al. 2005). AP2γ protein is 
also expressed in a subset of apical ventricular zone progenitors including the population that starts to 
express Tbr2 (Pinto et al. 2009). This protein is present in numerous regions of the adult mouse brain, 
specifically in the GCL of the adult cerebellum and in the white matter of the forebrain (Pinto et al. 
2009).  AP2γ mRNA is highly expressed in both of the referred neurogenic niches (SGZ of the DG and 
SEZ of the lateral ventricles), and also highly expressed in the RMS, in the GCL, glomerular layer and 
mitral cell layer of the OB (Pinto, 2008; Mateus-Pinheiro et al. 2016). In the SEZ, AP2γ is expressed in 
a group of bromodeoxyuridine (BrdU)-retaining stem cells, suggesting that the involvement of this 
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transcription factor might not be restricted to primordial developmental stages, and that can be involved 
in adult glutamatergic neurogenesis (Pinto, 2008).  
All of the above observations strongly suggest that AP2γ functional role is not restricted to 
primordial developmental stages, being also involved in the modulation of the adult glutamatergic 
neurogenesis. Therefore, characterizing this transcription factor is crucial to understand its functional 
relevance in the regulation of the adult hippocampal neurogenic process. Recently published findings 
from our group, showed AP2γ transcription factor as a positive regulator of adult neurogenesis in the 
hippocampal DG, as its overexpression increments the generation of new neurons in this region, and its 
deletion, both in vitro and in vivo, results in a marked reduction of the neuroblasts population (Mateus-
Pinheiro et al. 2016). Mechanistically, AP2γ acts as an effector of Sox2 and Pax6 in the promotion of 
Tbr2 expression in hippocampal progenitor cells. AP2γ expression produces a net effect in Tbr2 protein 
levels within the hippocampal DG (decreasing significantly when deleting AP2γ), suggesting that AP2γ 
regulates post-natal glutamatergic neurogenesis by mobilizing TAPs, rather than interfering with the 
NSCs pool. The presence of an alternative regulatory pathway using AP2γ as an intermediate 
transcription regulator, in parallel with direct regulation of Tbr2 by Pax6, suggest that AP2γ function 
may allow a fine-tuning of the neurogenic process, by either rapidly expanding or restricting the TAPs 
pool.  
In summary, AP2γ is an important modulator of the adult hippocampal neurogenic process, 
and as such this transcription factor may be a promising target to use for novel therapeutical tools in 
pathological conditions in which neurogenesis is affected. 
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1.2.4. Epigenetic regulation of adult hippocampal neurogenesis: DNA methylation 
and DNA demethylation as epigenetic choreographers 
 The concept of epigenetics was first introduced almost a century ago to describe the molecular 
events that are involved in early embryonic development (Yao et al. 2016). Epigenetics is now widely 
accepted as the interface between genes and the environment, using for this, cellular processes that do 
not change the genomic sequence, but have the ability to elicit relatively persistent biological effects 
(Ma et al. 2010). Several mechanisms have been hardly associated with changes in gene expression, 
that do not arise from alterations in DNA sequence, among which we can find: DNA methylation, DNA 
demethylation, histone modifications, chromatin remodeling and regulation mediated by non-coding 
RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) (Yao et al. 2016). Despite 
being a relatively recent concept in the neuroscience field, different epigenetic mechanisms have been 
linked with pivotal roles in different stages of neurogenesis. The participation of these epigenetic 
mechanisms in the regulation of NSCs proliferation, fate specification and differentiation, is now 
Figure 4. Transcriptional factors involved in the regulation of the adult hippocampal neurogenic process 
The different neuronal developmental steps in the adult hippocampal neurogenic process are largely associated with the 
expression of different transcriptional factors. Sox2 is a transcription factor that controls the development of the nervous 
system from its earliest stages, being highly expressed by NSCs. Pax6 is highly involved in the brain development being 
highly expressed by type 1 and type 2a cells. AP2γ transcription factor, besides having key roles in developmental stages, 
integrates this transcriptional network, acting as a downstream target of Pax6 and having key modulatory actions upon Trb2 
and NeuroD. Ngn2 transcription factor is expressed by type 2a cells, whereas Tbr2 and NeuroD are expressed by type 2b 
and type 3 cells, having key modulatory actions upon the neurogenic process. Tbr1 is expressed by immature neurons and 
granule cells, displaying important roles also in the cortical formation. Prox1 is also expressed in immature granular cells 
with specific roles in cell development. CREB and REST transcription factors are expressed by both immature and mature 
granule neurons, being involved in neuronal survival, fate choice and differentiation. 
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becoming to be recognized as fundamental for the balanced production of new neuronal and glial cells, 
needed for the homeostatic brain function (Mateus-Pinheiro et al. 2011). Cumulative evidence now 
suggests that epigenetic dysregulation also plays an important part in neurodegenerative disorders, and 
more interestingly, in psychiatric disorders (Yao et al. 2016). 
Epigenetic mechanisms are becoming gradually accepted to play dynamic roles in adult 
neurogenesis. Notably, the intracellular epigenetic program regulating adult neurogenesis is suggested 
to be quite similar to the epigenetic modulation occurring during the embryonic developmental 
neurogenesis, but is also determined by new extrinsic physiological and environmental stimulus that 
allow the alignment of neurogenesis with the external needs (Ninkovic and Gotz 2007). Even though 
epigenetics in the field of adult neurogenesis is still in its nascent stage, a global picture of the 
epigenetic involvement on this field begins to emerge (Figure 5). 
Although there are different epigenetic mechanisms playing important and specific roles in 
adult hippocampal neurogenesis, in this work we mainly focused in two: DNA methylation and DNA 
demethylation. 
 
1.2.4.1. DNA methylation 
 DNA methylation involves the chemical covalent addition of a methyl group to the fifth carbon in 
the cytosine pyrimidine ring: that is, the production of 5-methylcytosine (5mC). Usually, studies of DNA 
methylation have focused on regions that enclose a high frequency of CG dinucleotides, which are 
commonly known as CpG islands (Montalban-Loro et al. 2015; Yao et al. 2016). In most mammalian, 
CpG islands are hypomethylated, which ensures genomic stability, imprinted gene silencing and X-
inactivation. Interestingly, it was found that the majority of the dynamic DNA methylation in neurons 
does not occur at CpG islands and instead takes place in regions low in CpG densities (Yao et al. 
2016). After the DNA methylation marks are established, a group of methyl-CpG-binding proteins 
behave as readers to interpret 5mC signal and mediate its function. Methyl-CpG-binding domain protein 
1 (MBD1) occupies and protects the methylation of the promoter for basic fibroblast growth factor 2 
(FGF2), which generates growth factors essential for the neural development (Yao et al. 2016). The 
depletion of MBD1 impairs adult hippocampal neurogenesis and genomic stability, due to a 
hypomethylation and depression of FGF2 in NSCs, resulting in this way in the failure of these cells to 
differentiate (Zhao et al. 2003; Li et al. 2009). Also involved in DNA methylation reading are many 
transcription factors with specific binding to methylated and unmethylated DNA motifs of distinct 
sequences (Hu et al. 2013). Thus, in contrast to the prevalent idea that 5mC nucleotides diminishes 
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transcription factor binding, DNA methylation increases the variety of binding sites for transcription 
factors highly known to be involved in the regulation of neurogenesis (Yao et al. 2016). However, there 
is the need to understand these binding sites specificities and their effect on gene expression during 
neurogenesis. 
 
DNA methylation is catalyzed by a family of DNA methyltransferases (DNMTs) that are 
responsible for maintaining or producing 5mCs on the genome. There are two types of methylation 
reactions, both mediated by DNMTs. The de novo methylation, which is catalyzed by DNMT3a and 
DNMT3b, is highly important for embryogenesis, neural development and the establishment of 
methylation patterns (Montalban-Loro et al. 2015). The other methylation reaction is promoted by the 
action of DNMT1, and is responsible to copy the existing methylation patterns during DNA replication 
for inheritance. DNMT1 is abundantly expressed in the embryonic, perinatal, and adult CNS in both 
dividing NSCs and mature neurons, where it maintains DNA methylation state, whereas, DNMT3a and 
DNMT3b are highly expressed in postnatal NSCs and are required for neurogenesis and neuronal 
maturation (Montalban-Loro et al. 2015; Yao et al. 2016). A mutation in any of the three major DNMTs 
genes in mice leads to severe developmental abnormalities and embryonic, or early postnatal lethality 
Figure 5. Epigenetic regulators of the adult hippocampal neurogenic process. 
The adult hippocampal neurogenic process is exposed to a complex epigenetic regulation, with important functional 
implications. Distinct types of regulators have been identified and associated with different epigenetic mechanisms. Epigenetic 
regulators such as PcG protein and MDB1 are involved in the regulation of the initial steps of neurogenesis, contributing to 
NSCs self-renewal and maintenance. The transcriptional activation of specific genes by TrxG proteins, together with the action 
of chromatin remodeling complexes such as REST/CoREST complex and its molecular partners will allow the progenitor cells 
to exit the proliferation cycle and become committed to a neural cell lineage. The action of regulators like MeCP2, will 
contribute to post-mitotic neuronal differentiation and maturation. Some epigenetic regulators like HDACs, Hats and DNMTs 
are involved in several regulatory mechanisms of the adult neurogenic process, integrating several regulatory complexes 
involved in the transcriptional activation of pro-neurogenic genes. 
 
 
18 
(Li et al. 1992; Okano et al. 1999). In mice, a deficiency for DNMT1 leads to deficits of neuronal 
function and lethality in neural progenitors at embryonic stages (Montalban-Loro et al. 2015). In vitro, it 
was possible to see that the depletion of DNMT3a leads to gene silencing, and loss of DNMT3b 
promotes a deficient NSCs differentiation instead of proliferation (Martins-Taylor et al. 2012). Although 
at this point, there are some evidences regarding the functions of DNMTs in the neurogenic process, 
further studies are required to comprehend their genomic targets and their context-dependent roles. 
 
1.2.4.2. DNA demethylation 
 DNA methylation marks are reversible through both passive replication dependent 
demethylation and active demethylation. Involved in the active demethylation process are the ten-eleven 
translocation (TET) family of methylcytosine oxygenases, that in mammals comprise 3 members: TET1, 
TET2 and TET3. These enzymes promote an active DNA demethylation through the oxidation of 5mC 
into the recently characterized epigenetic marker 5-hydroxymethylcytosine (5hmC) (Tahiliani et al. 
2009). In further studies it was revealed that the TET enzymes could further oxidize 5hmC to 5-
formylcytosine (5fC) and then to 5-carboxylcytosine (5caC) (Yao et al. 2016).  
 The notion of DNA demethylation as a neurogenic choreographer emerged by the finding that 
growth arrest and DNA-damage-inducible protein 45β (GADD45β) promotes adult hippocampal 
neurogenesis (Ma et al. 2009; Yao et al. 2016). The GADD45 family members are highly associated 
with active DNA demethylation in different systems (Rai et al. 2008; Yao et al. 2016). In the embryonic 
and adult brain, GADD45β protein enhances promoter DNA demethylation and the expression of 
several genes, such as brain-derived neurotrophic factor (BDNF) and fibroblast growth factor 1 (Fgf1), in 
glutamatergic neurons, which in turn promotes the proliferation of NSCs and generation of new neurons 
in the hippocampal DG (Yao et al. 2016). Genome-wide profiling revealed that 5hmC is relatively 
abundant in the mouse ESCs, in the early developing embryo and also in the adult brain (Montalban-
Loro et al. 2015). During embryonic neurogenesis, 5hmC accumulates, as NSCs give rise to mature 
neurons, and its overall level continues to increase during ageing. By contrast, the differentiation of 
ESCs caused a reduction of 5hmC expression. Interestingly, the acquisition of 5hmC in several 
developmentally activated genes does not coincide with the demethylation of 5mC, confirming that 
5hmC itself can serve as an epigenetic marker (Yao et al. 2016).  
Until this moment, studies regarding the function of TET proteins in the brain are mostly 
focused on TET1, but it is already known that the different isoforms have preferences for distinct 
genomic sites to demethylate, suggesting in this way, that these proteins have independent but 
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interactive roles in neurogenesis (Santiago et al. 2014; Yao et al. 2016). TET1 was considered a key 
regulator for the progenitor cell pool in the hippocampal DG, since the KO mice for this gene exhibit a 
decreased number of NSCs in the adult SGZ, and these progenitor cells showed decreased proliferation 
capacities when isolated and grown as neurospheres (Huang et al. 2014). Regarding the function of 
both TET2 and TET3 in neurogenesis and in neuronal differentiation little is know, apart from some 
evidences showing that neuronal differentiation is accompanied by an upregulation of these proteins 
(Hahn et al. 2013). However, some insights regarding the role of TET3 in neurogenesis have emerged 
lately, through the depletion of this protein in Xenopus laevis embryos in which it was possible to see a 
repression of many key developmental genes also involved in neurogenesis, such as Pax6, Ngn2 and 
Sox2 (Yao et al. 2016).  
 Although there is some progress in the elucidation of the DNA demethylation role in the 
neurogenic process, there are still a lot of blank spaces. Importantly, we still need to understand how 
this epigenetic mechanism is influencing the adult neurogenic process, and its interactions with other 
epigenetic intervenients regulating adult hippocampal neurogenesis.  
 
1.3. Implications of adult hippocampal neurogenesis deregulation in the 
etiopathogenesis of depression 
 
1.3.1. Adult hippocampal neuroplasticity on the pathophysiology of depression 
 Adult hippocampal neurogenesis represents a crucial form of neuroplasticity in the 
hippocampal formation, which is a brain structure deeply involved in various neuropsychiatric disorders 
(Kang et al. 2016). Deregulation of adult hippocampal neuroplasticity is currently accepted to be 
involved in the pathophysiology of several neuropsychiatric diseases (Balu and Lucki 2009). As 
highlighted in the first part of this thesis, possibly one of the most striking findings in this scientific field 
was the discovery of adult neurogenesis imbalances involvement in depression, leading to the so called 
“neurogenic hypothesis of major depression” (Kempermann et al. 2008). This was the first theory 
connecting adult neurogenesis imbalances to this psychiatric disorder, and even more important, the 
first cellular hypothesis of depression (Kempermann et al. 2008). It postulates that impairments on the 
production of new neurons and reduced neuroplasticity may be related to depressive-like behaviors, 
based primarily on findings that stress inhibits adult hippocampal neurogenesis, and causes dendritic 
atrophy (Schoenfeld and Cameron 2015). This hypothesis is being highly supported by different 
evidences linking reduced neurogenesis to depressive-behavior, and by the observed pro-neurogenic 
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action of different antidepressant drugs (ADs) (Bessa et al. 2009a; Kang et al. 2016). However, some 
precautions have to be taken in consideration when we describe the association between the 
neurogenic process and depression. For example, different studies used specific methods to ablate 
hippocampal neurogenesis, like irradiation, and depressive-like phenotype was not induced in animals. 
More so, there are descriptions in the literature of ADs with both neurogenic-dependent and neurogenic-
independent actions (Kang et al. 2016).  
A third link between hippocampal neurogenesis and depression lies in the functional 
importance of this specific neurogenic process in behavioral domains commonly affected in depressive 
patients, like mood, anxiety and cognition (Figure 6) (Dupret et al. 2008; Bessa et al. 2009a; Clelland 
et al. 2009). The relationship between adult hippocampal neurogenesis and these 3 dimensions 
affected in depression is rather complex and not yet fully understood. However, enhancement of 
hippocampal neurogenesis via exercise, pharmacological, or genetic manipulations, was shown to 
induce anxiolytic and antidepressant-like effect in animals, suggesting that increased neurogenesis is 
sufficient to modulate these behaviors (Wu and Hen 2014; Hill et al. 2015; Kang et al. 2016).  
In sum, hippocampal neurogenesis has a great impact in the pathophysiology of depression, 
both by being directly involved in the behavioral dimensions affected in depression or by indirectly 
mediating ADs efficacy in animals or patients suffering from this psychiatric disorder. As such, further 
insights in the mechanistic modulation of hippocampal neurogenesis in depression are needed, to more 
precisely evaluate the scientific validity of the neurogenic hypothesis of depression and possibly open 
up a new array of therapeutic targets to treat depression. 
 
1.3.2. Transcriptional and epigenetic deregulation of adult hippocampal 
neurogenesis as a possible precipitator of depression 
 Given the crucial role of adult neurogenesis in several aspects of brain function, such 
as cognitive, emotional and mood regulation it is not surprising that dysregulation of this process may 
contribute to various brain disorders. During the last decade, cumulative evidences have emerged for 
the participation of genetic and epigenetic regulatory mechanisms in adult hippocampal neurogenesis. 
Thus, dysfunctions in these regulatory mechanisms might be a key mediator of the neurogenic 
imbalances observed in some neuropsychiatric disorders, such as depression. 
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Several studies aimed to identify genes deregulated in depressive and other stress-related 
disorders. In one such study, human hippocampal progenitor cells in vitro were treated with high levels 
of cortisol during the proliferation phase, to mimic the effects of chronic stress exposure (Anacker et al. 
2013). Signaling pathway analysis of gene transcription revealed different pathways affected by the 
glucocorticoids treatment, including three well known to regulate adult neurogenesis, namely, the 
forkhead box protein O3 (FOXO3A) pathway, which was activated, the transforming growth factor-β 
(TGFβ)-SMAD2-SMAD3 and the Hedgehog pathway, which were inactivated (Egeland et al. 2015). 
Interestingly, gene transcription and subsequent analyses of hippocampal tissue from rodents exposed 
to prenatal stress showed similar results regarding the inactivation of Hedgehog and TGFβ-SMAD2-
SMAD3 pathways. Despite the fact that in vitro and in vivo comparisons should be carefully made, the 
consistency of results between the human neuronal cell line and the rodent hippocampus suggests that 
these signaling pathways are likely to be very important in the regulation of post-natal neurogenesis by 
stress exposure (Egeland et al. 2015). Another study using a rodent model revealed several changes in 
Figure 6. Impact of hippocampal glutamatergic neurogenesis in depression. 
Chronic stress exposure leads to hippocampal neuroplastic impairments causing dendritic atrophy on pre-existing granular 
neurons and compromising the generation of new neurons. Impairments in the hippocampal neurogenic process can be 
attributed to dysfunctions in transcriptional and epigenetic regulators, possibly leading to the multidimensional behavioral 
deficits associated with depression. 
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gene expression in the hippocampal DG after chronic stress exposure. In this study, exposure to a 
chronic stress protocol induced a decrease in the level of cAMP response element binding protein 
(CREB), impairing in this way this pathway and disabling the expression of genes involved in the adult 
glutamatergic neurogenic process (Datson et al. 2012). CREB is a transcription factor that controls 
adult neurogenesis, as its phosphorylation allows its binding to the brain derived neurotrophic factor 
(BDNF) promoter, thus modulating BDNF function (Kempermann 2011). BDNF has highly relevant 
roles in the adult glutamatergic neurogenesis process, being greatly involved in dendritic growth and 
spine maturation of hippocampal neurons. Moreover, in pathological conditions BDNF deficits leads to 
impairments in the adult neurogenic process, not only causing deficiencies in neuroplasticity but also 
impairing neuronal survival, differentiation and maturation (Kempermann 2011). Another indicator of 
the importance of BDNF in depressive conditions comes from the pharmacological action of ADs. One 
of the well known targets of ADs is indeed BDNF, which has an increased expression upon ADs chronic 
administration, leading to the reversal of neuronal atrophy and cell loss, further improving the 
behavioral output in anxiety, motivation and cognition (Martinowich et al. 2007). 
Moreover, phosphorylated CREB highly co-localizes with polysialylated form of neural cell 
adhesion molecule (PSA-NCAM) in the hippocampal DG (Nakagawa et al. 2002). PSA-NCAM is a well 
known cell-adhesion molecule known to be involved in many facets of neural plasticity, playing 
important roles in synaptic plasticity and mediating effects of neurotrophic factors like BDNF 
(Wainwright and Galea 2013). This molecule is reduced in depressed patients and in animal models of 
depression while chronic treatment with ADs increases its expression. Importantly, in pathological 
conditions decreased expression of PSA-NCAM, leads to impairments in adult neurogenesis, in neurites 
outgrowth and in the maturation of the synapse sites of mature neurons (Wainwright and Galea 2013). 
Although being still a controversial topic, several studies showed that impairments in epigenetic 
regulatory mechanisms of adult hippocampal neurogenesis are also affected in animal models of 
depression. This deregulation may contribute to aberrant expression of risk-associated genes causing 
negative impact on neurogenesis, and contributing in this way, to the pathophysiology of depression. A 
case supporting the epigenetic deregulation of adult neurogenesis in depression is the already 
mentioned methyl binding protein MBD1. In previous studies, by Allan and colleagues, showed that 
MBD1-deficient mice, besides having decreased NSCs proliferation, also displayed significant deficits in 
different behavioral dimensions affected by depression. These animals showed increased anxious 
phenotype both in elevated-plus maze (EPM) and light-dark box, cognitive deficits demonstrated during 
the execution of Morris water maze (MWM) spatial learning tasks and behavioral despair detected 
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through the forced swimming test (Allan et al. 2008). These different findings suggested that MBD1 
binding protein impacts on adult neurogenesis epigenetic modulation, and consequently in the 
pathophysiology of depression. 
Moreover, epigenetic regulators involved directly in post-mitotic neuronal maturation and 
differentiation, have also been related to different behavioral and cognitive impairments observed in 
various neuropsychiatric disorders, including depression. One well-known example is the methyl-CpG-
binding protein 2 (MeCP2), reported to be involved in adult hippocampal neurogenesis and in the 
pathophysiology of major depression. This well characterized epigenetic regulator is highly responsible 
for the expression of BDNF. Mechanistically, MeCP2 specifically recognizes methylated DNA at a 
promoter of the BDNF and further recruits the transcription repressors histone deacetylases (HDACs) 
and SIN3A (Yao et al. 2016).  Furthermore, it has been shown, using a MeCP2 KO mice, that deficiency 
in this binding protein causes reduction of hippocampal neurogenesis, severe deficiencies in the 
maturation of newborn neurons in the SGZ, including delayed differentiation and diminished dendritic 
spine density (Smrt et al. 2007). As such, MeCP2 may interfere in neurological pathways that mediate 
adult neurogenesis, and thus can be involved in its deregulation in a depressive situation. The DNMTs 
family of enzymes was also shown to be involved in epigenetic deregulation in depression, specifically 
causing impairments in memory formation (Miller and Sweatt 2007; Miller et al. 2008). Interestingly, an 
enzyme that belongs to this family, DNMT3b, has increased expression in depressive suicide 
completers (Poulter et al. 2008). 
 Another indicator of the involvement of epigenetic mechanisms deregulation involvement in the 
modulation of the neurogenic process and precipitation of depression can be endorsed by the 
pharmacological action of ADs in depression. The action of the antidepressant imipramine, a tricyclic 
agent with a well described pro-neurogenic action (Bessa et al. 2009a) and behavioral improving 
features in a socially defeated mice model, induces the downregulation of HDAC in the hippocampal 
region (Tsankova et al. 2006). Moreover, overexpression of specific HDACs, such as HDAC5, 
counteracts the positive behavioral effects of chronic treatment with imipramine in animal models. This 
deacetylase is involved in the regulation of adult hippocampal neurogenesis, controlling both newborn 
neurons maturation and also its survival (Mateus-Pinheiro et al. 2011). The clinical effectiveness as 
mood stabilizer of another used drug in depression, valproic acid (VPA), has been associated to its 
neurogenic improvement effect (Yu et al. 2009). Additional studies, proved that VPA alone, or in 
conjugation sodium butyrate or when administered with the antidepressant fluoxetine ameliorates 
performance in animal models of behavioral despair. Taking in consideration that VPA is an HDAC 
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inhibitor (HDACi), and that HDAC inhibition is a known target of adult hippocampal neurogenesis, these 
studies reinforced the importance of the pharmacological modulation of epigenetic regulators to the 
efficacy of some ADs (Mateus-Pinheiro et al. 2011). 
 Epigenetic deregulation is also involved in the vulnerability to stress, enhancing the 
susceptibility to stress-related disorders, such as depression. The role of epigenetics in stress is a quite 
recent concept, but it has been shown that in rats exposed to stress early in life, have an increased 
expression in a specific DNA binding protein REST (repression element 1 silencing transcription factor) 
– REST4. These animals showed higher susceptibility to high-levels of anxiety-like behavior and stress-
induced impairments in some cognitive domains, like spatial reference memory and attention (Uchida 
et al. 2010). In a different study, using a mice model with ablation of a crucial component of a 
repressive chromatin complex, KAP1, this epigenetic regulator was shown to impact on anxiety, since 
these KO animals showed high-levels of anxiety-like behavior and other significant stress-induced 
impairments (Bredy et al. 2010). These referred epigenetic mechanisms are not directly involved in the 
modulation of adult neurogenesis, but are a great example of the importance that deregulation of 
epigenetic factors may have in increasing susceptibility to depression (Mateus-Pinheiro et al. 2011). 
 In summary, there are mounting evidences strongly suggesting the crucial role of different 
genetic and epigenetic regulators in the modulation of adult hippocampal neurogenesis in some 
neuropsychiatric disorders. Therefore, it is important to study its deregulation in pathological situations, 
in order to truly understand the mechanism underlying its function and comprehend if it is suitable to 
use in therapeutical approaches. This will open a new range of therapeutical possibilities, since it will 
facilitate the design of new molecule-directed drugs to counteract the neuropathological effects of major 
depression. Also, characterizing and understanding the functional roles of these neurogenic modulators 
can lead to gene-directed therapies aiming to have a neuroprotective role in emerging psychiatric 
disorders. 
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2. RESEARCH OBJECTIVES 
 
Previous studies from the group unveiled an important function of the transcription factor AP2γ 
in the modulation of adult glutamatergic neurogenesis and behavior. The central objective of this master 
thesis is to further explore the impact of this transcription factor in brain neurophysiology and behavior 
during development and at adult stages, dissecting also its underlying mechanisms both in basal and 
depressive states. For this, the work was divided into 2 major parts: 
 
PART 1 
 In the first part of this thesis we characterized the constitutive AP2γ KO animal model, to 
discriminate if the molecular and behavioral deficits seen in the adult mice are indeed an adult 
response or if there is already an impact of AP2γ reduction on post-natal developmental stages and on 
juvenile stages. For this purpose, three objectives were designed: 
1) Explore the impact of AP2γ on post-natal developmental; 
2) Understand if reduction of AP2γ has impact on behavior of juvenile mice; 
3) Elucidate the mechanism of action of AP2γ on the modulation of post-natal glutamatergic 
neurogenesis.  
 
PART 2 
 In the second part of this thesis we aimed to bring some insights regarding the impact of AP2γ 
on depressive-like behavior. Therefore, we used both constitutive and conditional AP2γ KO animal 
models, and designed two main objectives: 
1) Investigate the impact of AP2γ on behavior of depressive-like animals; 
2) Study if AP2γ deficiency modulates adult hippocampal neurogenesis in depressive-like 
animals. 
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3. MATERIALS AND METHODS  
3.1. Animals 
  
The experimental procedures performed in this master thesis were conducted in accordance 
with the Portuguese national authority for animal experimentation, Direcção-Geral de Alimentação e 
Veterinária (ID: DGAV4542). Animals were kept and handle in accordance with the guidelines for the 
care and handling of laboratory animals in the directive 2010/63/EU of the European Parliament and 
of the Council. Efforts were made to minimize the number of animals used and their suffering.  
To all animals was given the standard diet (4RF25 during gestation and postnatal periods, and 
4RF21 after weaning; Mucedola SRL, Settimo Milanese, Italy) and water ad libitum, with exception to 
the privation periods that occurred whenever the experiment required so. After weaning, animals were 
group-housed (3-5 per cage) and maintained under standard laboratory conditions on a 12/12h 
light/dark cycles (lights on at 8 a.m.) with an ambient temperature at 22ºC, and relative humidity of 
55%. 
In order to address the proposed objectives two animal models were used. To fulfill the first 
part of this thesis the constitutive AP2γ KO animal model was used, and for the second part both 
constitutive and conditional AP2γ KO animal models were used. 
Constitutive AP2γ KO animal model: 
AP2γ heterozygous KO (AP2γ+/-) mice (kindly provided by Dr. Hubert Schorle, Institute for 
Pathology, University of Bonn Medical School, Bonn, Germany) were maintained in a SV/129 
background and identified the genotypes by PCR of genomic DNA. For the post-natal evaluation of the 
developmental milestones, male animals were divided according to its genotype: WT (n=9) and AP2γ+/- 
(n=9) animals. Due to the strong side effects of the developmental milestones protocol a different set of 
male animals was used for the juvenile behavior and histological evaluation, and once again the 
animals were divided according to its genotype: WT (n=12) and AP2γ+/- (n=10) animals. Adult male 
animals with 2 months of age were divided into four experimental groups: WT control mice (n=8), 
AP2γ+/- control mice (n=7), WT mice exposed to uCMS (n=8), and  AP2γ+/- exposed to uCMS (n=7). 
 
Conditional AP2γ KO animal model: 
AP2γloxP/loxP (AP2γfl/fl) conditional KO mice (being loxP a locus of crossing over of bacteriophage) 
and Glast:CreERT2 mice were maintained on a SV/129 and C57Bl/6J background and the genotypes 
were identified by PCR of genomic DNA. loxP sites flanked exon 5, whose deletion caused a loss of the 
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helix-span-helix domain near the protein carboxyl terminus. AP2γfl/fl mice were crossed with 
Glast:CreERT2. Both male WT (AP2γ+/+//Glast:CreERT2+/-, henceforth referred to as cAP2γ+/+) animals and 
KO (AP2γfl/fl//Glast:CreERT2+/-, henceforth referred to as cAP2γ-/-) mice with two months of age were 
divided into four experimental groups: cAP2γ+/+ control mice (n=12), cAP2γ-/- control mice (n=5), cAP2γ+/+ 
mice exposed to uCMS (n=12) and cAP2γ-/- mice exposed to uCMS (n=8). 
 
3.2. Genotyping 
  
After collecting tail tips, the samples were transferred into 300 µL of lysis solution (Citogene, 
Brazil) with 1.5 µL of Proteinase K (Thermo Scientific, USA) and incubated overnight at 55ºC. In the 
following day, 100 µL of protein precipitation solution was added (Citogene), and after tissue lysis was 
completed, bones and hairs were removed through centrifugation [5 min at 13000 rotations per minute 
(rpm)]. The supernatant was transferred to 300 µL of cold isopropanol tubes that were inverted several 
times until the DNA precipitation was completed. Afterwards, the tubes were centrifuged for 5 min at 
13000 rpm, the supernatant was rejected and the DNA pellet was washed with 300 µL of ethanol 70%. 
To remove the ethanol, a centrifugation was performed for 1 min at 13000 rpm, and the supernatant 
was carefully discarded, leaving the pellet to dry at room temperature (RT) for 1 h. The DNA was then 
dissolved in DNase and RNase free water (Sigma, USA) at 65ºC for 1 h. DNA concentrations were 
accessed through the use of NanoDrop (ND-100 Spectrophotometer, Alfagene, Portugal) apparatus, 
and adjusted to a final concentration of 50 ng/µL.  
To access the genotype of mice with one null allele of the AP2γ gene, it was used 2 µL of DNA 
(extracted like it was described) as a template for a multiplex polymerase chain reaction (PCR) using the 
primers presented in Table 1.  
 
The primers P1 and P2 are used to identify the WT allele (343 bp), through an amplification of 
this allele, while the P3 primer allows us to identify the null allele (700 bp) of the AP2γ gene (Figure 7).   
Primer abbreviation Primer database code Sequence TM (°C) 
P1 Ap2γ_In4down 5’-aacaggttatcatttggttgggatt- 3’ 61 
P2 Ap2γ_Ex5up 5’-caattttgtccaacttctccctcaa-3’ 62,5 
P3 Ap2γ_Ex6up 5’-aatagtcagccaccgctttactagg-3’ 65 
Table 1. List of PCR primers sequence needed to genotype AP2γ gene and respective melting temperature (TM) 
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To genotype GLAST: CreERT2 mice it was used 2 µL of DNA as a template for a multiplex PCR 
using the primers presented in Table 2. 
 
Figure 7. Representation of the 6-kb genomic fragment of AP2γ. 
The exons are numbered and identified in grey. Primers P1 and P2 were used to amplify the WT allele, while the P3 was 
used to distinguish the null allele. Adapted from (Mateus-Pinheiro 2011). 
 
Table 2. List of PCR primers sequence needed to genotype GLAST: CreERT2 mice and respective melting 
temperature (TM) 
 
The primers P4 and P5 were used to amplify the WT allele (700 bp), while the P6 primer 
allowed to identify the recombinant allele (400 bp). 
To perform the PCR, a thermal cycler (MWG AG Biotech Primus 96 plus, Cole-Parmer, USA) 
was used. The PCR tubes (Sarstedt, Germany), with a total volume of 20 µL of the master mix and 
reaction conditions, are presented in Table 3. 
 
Table  3. Primer mix composition and reaction conditions 
Primer abbreviation Primer database code Sequence TM (°C) 
P4 GLAST_F8 5’-gaggcacttggctaggctctgagga- 3’ 71 
P5 GLAST_R3 5’-caggagatcctgacccgatcagttgg -3’ 69 
P6 CER1 (CreERT2 specific primer) 5’-ggtgtacggtcagtaaattggacat-3’ 64 
Reagents 
Master mix AP2γ 
genotyping  
Master mix 
GLAST:CreERT2 
Genotyping   
DNA 
template 
AP2γ PCR conditions GLAST:CreEr
T2 PCR 
conditions 
P1 (10μM) 1 μL - 
3 μL (50ng/ 
μL) 
95ºC 120’’ 
 
40 cycles of: 
95ºC 45’’ 
55ºC 35’’ 
72ºC 60’’ 
 
72ºC 180’’ 
4ºC ∞ 
94ºC 120’’ 
 
40 cycles of: 
94ºC 20’’ 
55ºC 20’’ 
72ºC 30’’ 
 
72ºC 300’’ 
4ºC ∞ 
P2 (10μM) 1 μL - 
P3 (10μM) 1 μL - 
P4 (10µM) - 1 μL 
P5 (10µM) - 1 μL 
P6  (10µM) - 1 μL 
Taq 
Polymerasea 
0.4 μL 0.4 μL 
Taq Bufferb 10 μL 5 μL 
Q solution 
(Quiagen, 
Germany) 
- 6 μL 
H2O (Sigma) 3.6 μL 12.6 μL 
a Nzytech Taq DNA Polymerase (recombinant) (5u.μL-1) 
b Nzytech Taq Buffer with 1 mM DTT; 20mM Tris-HCl (pH 7.5 at 25ºC); 0.1M EDTA; 50% (v/v) glycerol 
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PCR products were separated in a 3% agarose gel stained with Greensafe premium (Nzytech, 
Portugal). The gel was obtained by mixing 100 mL of TAE (Tris base, Acetic acid and EDTA) buffer with 
3 g of agarose (GeneON, UK), and then, 3 µL of Greensafe premium was added. After the gel 
polymerization was completed, 3 µL of 6xDNA loading dye (Fermentas, USA) was added to each 
sample, and 10 µL of the referred samples were charged in different wells. To guarantee a correct 
interpretation of the size bands, to each row of the gel 4 µL of 1kb DNA ladder (0.5µg/μL GenerulerTM 
Fermentas) was loaded in 2 wells. The electrophoresis occurred at 100 V for a period of 30 min. After 
completion of the run, the gel was visualized on a cassette of the GeldocTM IZ imager (Biorad, USA), and 
the image obtained was cut and cleaned using Image LabTM Software (Biorad). 
 
3.3. In vivo tamoxifen injections  
  
To promote inducible excision of AP2γ, all AP2γ conditional KO animals groups (both cAP2γ+/+ and 
cAP2γ-/-) were injected with tamoxifen (T-5648, Sigma, USA). Tamoxifen was dissolved in corn oil (Sigma; 
C-8267) at 20 mg/mL and 1 mg was injected intraperitoneally (i.p.) twice a day for 5 consecutive days 
(Mori et al. 2006; Feil et al. 2009). After a 7 days’ interval period, this process was repeated once 
more. 
 
3.4. Unpredictable chronic mild stress protocol 
  
Both animal models (AP2γ constitutive KO model and the AP2γ conditional KO model) were 
exposed to a unpredictable chronic mild stress (uCMS) protocol, which is described and employed in 
rats (Bessa et al. 2009b), but in previous studies from the group, the employment of this protocol with 
some adaptions induced core depressive-like symptoms in mice. Briefly, the uCMS protocol 
encompasses several mild stressors: confinement to a restricted space for 1 h; housing in an 
overcrowded cage for 1 h; housing in shaking cages for 2 h; overnight housing in titled cages; overnight 
damp bedding; exposure to stroboscopic lights during 4 h and noise exposure for 4 h. Animals were 
random exposed to these stressors during 6 weeks. Control animals were handled every week 
throughout the protocol. All behavioral analyses were conducted after the uCMS period (weeks 7 and 8) 
during the diurnal phase, between 09:00 am and 18:00 pm.  
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3.5. Serum corticosterone measurements 
 
 At the end of the uCMS protocol, blood samples were collected in order to assess the level of 
corticosteroids on both adult AP2γ KO animal models (AP2γ constitutive KO model: nControl WT=8; nControl AP2γ+/- 
=8; nuCMS WT=7; nuCMSl AP2γ+/- =7; AP2γ conditional KO model: nControl cAP2γ+/+=12 ;nControl cAP2γ-/- =5; nuCMS cAP2γ+/+=12 ;nuCMSl cAP2γ-/- 
=8). This was performed to evaluate if indeed the uCMS protocol induced core molecular alterations in 
the animals subjected to this stress protocol, since corticosterone is a major indicator of stress (stress 
increases the production of corticosteroids). Blood sampling (tail venipuncture) was performed during 
the diurnal nadir (N, 08.00-09:00) and nocturnal zenith (Z, 20:00-21:00), with an interval of 24 h in 
between. Serum was obtained by centrifugation (13000 rpm for 10 min) and stored at -20ºC until 
further analysis. Subsequent serum corticosteroid levels were measured by corticosterone enzyme-
linked immunossorbant assay (ELISA) kit, following the instructions provided by the manufacture (Enzo 
Life Sciences, Switzerland) 
 
3.6. Behavioral tests 
   
3.6.1. Developmental milestones  
 The assessment of the neurobehavioral neonatal development included the performance of a 
diverse and well-described range of tests (Lim et al. 2008). These tests were used to evaluate different 
neurologic parameters such as motor coordination, spatial and auditory reflexes, and strength 
development. This procedure was designed to allow a fast analysis so that several animals could be 
examined daily in a relatively short period of time, reducing in this way the stress induced in the 
mothers and litter (Lim et al. 2008).  
 The day of birth was considered as postnatal day (PND) 0, and after some experience with the 
protocol we decided to not perform any kind of test in this day due to be too traumatic for the mothers. 
From this day on, mice were daily inspected for the acquisition of developmental milestones and weight 
gain until PND21, the weaning day. To allow a fast identification of each mouse, pups were numbered 
and only after the weaning day, tail tips were cut to genotyping purposes.  
 On the day of testing, the home cage was moved into the testing room and left to habituate for 
at least 15 min. During the experimental performance, the pups were left in the same room as the 
mother and the separation time was minimized as possible. The experimenter was always the same 
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and the execution of each test was random, as well as the animal’s order. The experiment procedures 
were conducted blind to genotype. 
 This developmental milestones protocol encompasses several tests that have to be performed 
in a specific a range of time during the 21 days (Table 4). The results of the tests have in consideration 
the time to accurately perform, or reply to a stimulus or posture. Thus, the latency of time (in seconds, 
s) that the animal took to perform the test was registered and later converted to dichotomic scores, as 
indicated in Table 5, allowing in this way a quantitative measurement of the behavior. The animal is 
considered to display the mature response on a specific test when the highest score is attributed for 
three consecutive days. 
 This developmental milestones protocol can be divided into two major categories of tests: test 
that assess somatic parameters and tests that evaluate neurobiological reflexes (Table 6). 
 
Table  4. Data sheet for developmental milestones  
Neonatal mouse pups were examined daily from PND 0 to 21 for performance on a wide range of developmental tests 
evaluating strength, motor coordination and the appearance of reflexes. The shaded areas identify the different tests 
performed on each day. 
Milestones tests 
Postnatal day 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
Weight                       
Anogenital distance                       
Surface righting                       
Negative geotaxis                       
Cliff aversion                       
Rooting                       
Postural reflex                       
Wire suspension                       
Walking                       
Grasping                       
Auditory startle                       
Ear twitch                       
Open field                       
Air righting                       
Eye opening                       
Homing                       
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Somatic Parameters 
 As a measure for morphological development animals were daily weighed and the anogenital 
distance (which refers to the distance between the anus and the opening of the genitalia) was also 
measured. The opening of both eyes was inspected everyday and scored according to Table 5. 
 
Neurobiological reflexes 
 Surface righting, PND1-13 (Labyrinthine reflex and body righting mechanism, strength and 
coordination). The mouse pup was held gently (in the four limbs) on its back and released. The time for 
the pup to flip over with all four paws touching the surface of the soft screen was registered, and later 
converted into dichotomic scores. If the animal did no responded within 30 s, the test was ended. When 
the pups were able to right themselves in less than 1 s for three consecutive days, the mature response 
was attributed. 
 
Negative geotaxis, PND1-14 (Labyrinthine reflex and body righting mechanism, strength and 
coordination). The animal was placed head down on a square of a scratchy screen set at an angle of 
45º. The latency of time for the pup to turn 180º to the “head up” position was recorded and converted 
to a dichotomic score. If the pup lost footing and slipped on the screen, the test was repeated once 
more. If the animal did not respond within 30 s, the test was stopped. The test was daily repeated and 
the mature response was attributed once the animal performed correctly the movement in less than 30 
s for three consecutive days.   
 
Cliff aversion, PND1-14 (Labyrinthine reflex and body righting mechanism, strength and 
coordination). The animal was placed on the edge of a small box, with the digits of the forepaws and 
the snout hanging over the box. The time that it took the animal to turn and begin crawling away from 
the edge was registered and later converted to a dichotomic score. If the pup lost footing and slipped off 
the box, the test was repeated once more. If the animal did not respond within 30 s, the test was 
stopped. The test was daily repeated and the mature response was attributed once the animal 
performed correctly the movement in less than 30 s for three consecutive days.  
 
Air righting, PND8-21 (Labyrinthine reflex and body righting mechanism, strength and 
coordination). In this test the pup was held upside down and released from a height of approximately 
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30 cm, while its landing position was observed. The mature response was recognized when the animals 
landed on all four paws for three consecutive days.  
 
Table  5. Adaptation of time latency registered for each test into dichotomic scores  
[adapted from (Hill et al. 2008)] 
Milestones tests 
Score 
0 1 2 3 
Surface righting No response within 30 s 
Rights itself but slowly (10 - 
25 s) 
Rights itself but it takes 
around 10 s to do it 
Rights itself immediately 
Negative geotaxis No response within 30 s 
Turns its body 180º to the 
“head up” position in less 
than 30 s 
  
Cliff aversion 
Freezes/does not respond 
within 30 s 
Turns very slowly back to 
the surface (10 - 25 s) 
Avoids the cliff, but it still 
takes some time to turn (up 
to 10 s) 
Turn back in less than 3 s 
Rooting 
Does not move the head 
towards the filament 
Moves the head towards 
the filament in one way 
Moves the head towards 
the filament in two ways 
 
Postural reflex Not present Present   
Wire suspension Falls immediately  
Grasps the bar with all four 
limbs (maximum time set 
30 s) 
  
Walking No locomotion 
Pivoting – moves around 
with the help of and 
forelimbs, but it does not 
uses the hind limbs 
Crawling – Moves around 
with all four limbs, but it 
still drags the belly over the 
surface 
Walking – Mature 
locomotion with body fully 
supported by the four limbs 
Grasping No grasping 
Places its paws on the thin 
wire, but it does not hold on 
firmly 
Places its paw on the thin 
wire, but when the stick is 
pulled, it can not hold it 
Grasps the thin wire very 
firmly 
Auditory startle No response Reacts to the sound   
Ear twitch Not present Present   
Open field No response within 30 s 
Moves out of the arena in 
less than 30 s 
  
Air righting Lands on its back 
Lands on the surface with 
all four paws 
  
Eye opening Both closed One eye open Both eyes open  
 
Rooting, PND1-12 (Tactile reflex and motor coordination). To perform this test a fine filament 
of a cotton bud was used. The filament was gently and slowly rubbed from front to back alongside of 
the animal’s head. It was considered a successful test if the pup moved it head towards the filament. 
The test was repeated on the other side of the head to evaluate the appearance of this neurobiological 
reflexes on both sides. If the animal did not respond to the filament the test was repeated once. The 
mature response was recognized when the animals responded on both sides to the cotton filament for 
3 consecutive days. 
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Grasping, PND5-21 (Freeing reflex). The mouse palm forelimb was stimulated with a thin wire. 
This reflex disappears with the development of the nervous system, and because of that the mature 
response was assumed to appear as soon as the animal grasped firmly the thin wire immediately. 
 
Postural reflex, PND5-21 (Reflex). The pups were placed in a small plastic box and gently 
shaken up and down and left and right. When the animals were able to maintain its original position in 
the box by extending all four paws, it was assumed that the animals acquired the mature response.  
 
Auditory startle, PND7-18 (Auditory reflex). In this test the animals were placed on a 
laboratory bench and had to react to a handclap at a distance of 10 cm. When the pups responded 
correctly with a quick involuntary jump for three consecutive days it was presumed that the animals 
developed the mature response. 
 
Ear twitch, PND7-15 (Tactile reflex). To execute the test a fine filament twisted from a cotton 
swab was used to gently brush the ear of the pups three times. The animal was considered to 
accomplish a mature response when it responded by flattening the ear against the side of the head for 
three consecutive days. 
 
Wire Suspension, PND4-14 (Strength). The animal, hold with its forepaws in a 3-mm 
diameter metal wire suspended at 5 cm above a soft surface, was released and the interval of time that 
the pup maintained grasping the thin wire was acquired. If the pup immediately failed off, the test was 
repeated once more. The mature response was achieved when the animal was able to grasp the bar 
holding it with all four paws.  
 
Open field, PND8-21 (Locomotive coordination). To execute this test, the animal was placed 
in a small and adapted arena (a circle with 13 cm in diameter), and the interval of time taken to move 
was recorded. If the pup was not able to move, the test was ended. When the mouse was able to leave 
the circle in less than 30 s in three consecutive days, it was considered that the animal presented a 
mature response.  
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Walking, PND5-21 (Locomotive coordination and muscular strength). In this test, the animals 
were able to freely move around on the laboratory bench for 60 s. The mature response was achieved 
when the animals were able to move with the body completely supported by the four limbs. 
 
Homing, PND12 (Locomotive coordination and olfactory capabilities). Individual animals were 
placed in the center of a standard cage containing 1/3 of bedding from the home cage and the 
remaining of the cage with new clean bedding. In this test it was assessed the latency to turn and move 
onto the home cage bedding in three separate trials. Each trial lasted a maximum of 120 s with an 
inter-trial interval of 10 s. The mouse was considered to recognize the home cage bedding when all four 
paws had crossed onto the home bedding and the pup remained there for at least 10 s. 
 
Table  6. Summary of each test analyzed and its evaluated dimension  
 
 
  
Milestones tests Somatic Reflexes Coordination Strength Vestibular Olfactory 
Weight       
Anogenital distance       
Eye opening       
Surface righting       
Negative geotaxis       
Cliff aversion       
Air righting       
Rooting       
Wire suspension       
Walking       
Open field       
Grasping       
Postural reflex       
Auditory startle       
Ear twitch       
Homing       
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3.6.2. Elevated-plus maze 
The elevated-plus maze (EPM) is a widely used behavioral assay for rodents and it has been 
validated to access mechanisms underlying anxiety-related behavior (Walf and Frye 2007). The 
assessment of anxiety-like behavior of the rodents is possible through the ratio of time spent on the 
open arms to the time spent on the closed arms. Unlike other behavioral tests used to evaluate anxiety 
responses upon the presentation of noxious stimuli, that typically produce a conditioned response, the 
EPM relies on rodents tendency to explore novel environments (Bailey and Crawley 2009). Despite of 
this tendency, mice tend to prefer dark, enclosed spaces (approach) and have an unconditioned fear of 
heights/open spaces (avoidance) (Walf and Frye 2007). This approach-avoidance conflict results in 
behaviors that have been correlated with increases in physiological stress indicators. 
 A black propylene-made EPM apparatus (ENV-560; MedAssociates, USA) was used, and it 
basically consists in two opposite open arms (50.8x10.2 cm) in perpendicular orientation towards two 
additional opposite closed arms (50.8x10.2x40.6 cm), elevated 72.4 cm above the floor. The central 
area connecting both arms measured 10x10cm. Each animal was individually positioned in the center 
of the maze, facing an edge of a closed-arm and was allowed 5 min of exploration. Behavior parameters 
were recorded using an infrared photobeam system. Videos were analyzed using the video tracking 
software Ethovision XT (Noldus, Netherlands). 
 
3.6.3. Open Field test 
The open field (OF) is a commonly used test to evaluate anxious-like behavior and measure 
exploratory behavior and general activity in rodents. In order to do that, different parameters have to be 
measured: for instance, to evaluate the movement it is necessary to take in consideration distance 
traveled and time spending moving. Anxiety-like behavior can be assessed by measuring the activity in 
the center of the arena and comparing it with the activity that the animal has in the peripheries of the 
OF (Bailey and Crawley 2009). Normally decreased time and ratio central/total locomotion or latency to 
enter in the central part of the arena is an indication of anxiety-like behavior (Prut and Belzung 2003). 
 The OF apparatus consisted of a highly illuminated square arena of 43.2x43.2 cm, closed by a 
30.5 cm high wall. Mice were placed individually in the center of the OF arena and their movement was 
traced for 20 min (in juvenile animals) and 5 min (adult mice), using a 16-beam infrared system. The 
resulting data was analyzed using the Activity Monitor software (MedAssociates).  
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3.6.4. Forced Swimming test 
 Learned-helplessness was evaluated through the forced swimming test (FST) for the 
assessment of depressive-like behaviors. The experimental parameters employed in the FST were 
conducted using a slightly modified protocol described by Porsolt and colleagues 1977 (Porsolt et al. 
1977). Briefly, each animal was individually placed in glass cylinders filled with water (23ºC; depth 30 
cm) for 5 min. Test sessions were video-recorded and the immobility time was measured using the 
video tracking software Ethovision XT (Noldus). Through this software it was possible to define different 
parameters to ashore that indeed the animal is immobile. A mouse was judged immobile when it 
ceased all active behaviors (struggling, swimming and jumping) and remained passively floating or 
making minimal movements need to maintain the nostrils above water. To assess learned-helplessness, 
the first 3 min of the single session trial was considered as a habituation period and the last 2 min as 
the test period. Therefore, only the last 2 min of the trial were considered for behavioral analysis.  
 
3.6.5. Tail suspension test 
 The tail suspension test (TST) is also a commonly used behavioral test to assess depressive-like 
features in mice. The principle of this behavioral paradigm is highly similar to the FST, evaluating also 
the learned-helplessness of the animals. In this test, mice were suspended by the tail to the edge of a 
laboratory bench 80 cm above the floor (using adhesive tape), during 6 min (both for juvenile and adult 
mice). Trials were video-recorded, and immobility and climbing time was measured through the use of 
video tracking software Ethovision XT (Noldus). To assess learned-helplessness the first 3 min of the 
single session trial was considered as a habituation period and the last 3 min as the test period. 
Therefore, only the last 3 min of the trial were considered for behavioral analysis. 
 
3.6.6. Sucrose splash test 
 The sucrose splash test, henceforth referred as splash test, as described by Yalcin and 
colleagues (Yalcin et al. 2008) consists in spraying a 10% sucrose solution on the dorsal coat of mice in 
their home cage. Because of its viscosity, the sucrose solution dirties the coat and induces grooming 
behavior. After applying the sucrose solution, the time spent grooming was video-recorded for a period 
of 5 min as an index of self-care and motivational behavior, and then manually analyzed using the 
behavioral scoring program Observador v.0.2.7 (Department of Pharmacology, University of Athens). 
Due to the simplicity of this paradigm, this behavioral test was only applied in the juvenile AP2γ 
constitutive KO animal model to analyze if there were any differences between WT and AP2γ+/- animals. 
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3.6.7. Cognitive function assessment 
 For the assessment of the cognitive function in both adult AP2γ KO animal models two well 
described behavioral paradigms were used, the Morris water maze (MWM), and the contextual fear 
conditioning (CFC) tests. 
 
 3.6.7.1. Water Maze Tasks 
 The water maze tests were used to assess the performance in spatial reference and behavioral 
flexibility tasks as described by Bessa and colleagues (Bessa et al. 2009b). These tests were conducted 
in a circular white pool (170 cm diameter) filled with water at 22ºC to a depth of 34 cm in a room with 
extrinsic clues (triangle, square, cross and horizontal stripes) and a dim light. The water tank was 
divided in four quadrants by imaginary lines and a clear acrylic platform (12 cm diameter; 30 cm high), 
was placed in one of the quadrants. Trials were video captured by a video tracking system (Viewpoint, 
Champahne au mont d’or, France). 
 
Working memory task: 
 The working memory task (Cerqueira et al. 2007) was used to estimate the cognitive domain 
that relies on the interplay between the hippocampal and pre-frontal cortex (PFC) functions. The goal of 
this task, that results from adaptations on the original spatial reference memory test (Morris 1984), is 
to evaluate the capacity of animals to learn the position of the clear and hidden platform and to retain 
this information for four consecutives trials. The platform was placed in one of the quadrants, and it 
was maintained in the same position during the four daily trials. This task was evaluated during a period 
of 4 days, and in each day the platform was repositioned in a new quadrant in a clockwise-fashion. In 
each of the daily trials animals were positioned in a different starting point (north, east, west, and 
south) and a trial was considered terminated when the platform was reached within the time limit of 
120 s. If the animals did not reach the platform during the trial time, they were guided to the platform 
and allowed to stay in it for 30 s. The time of escape latency and the path described to reach the 
platform (distance swam) were recorded for each trial. 
 
 Reference memory task: 
 Through this water maze task, it was possible to assess the hippocampal dependent cognitive 
function. Briefly, in order to determine this task, the platform remained for 4 days in the same quadrant 
and animals were tested in 4 daily trials according to the same procedure previously described in the 
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working memory task. The time of escape latency and the path described to reach the platform 
(distance swam) were recorded for each trial.  
 
Reversal learning task: 
 After conducting tests for 4 days, maintaining the platform in the same quadrant, the reversal 
learning performance of animals (which is a PFC dependent function) was tested by positioning the 
platform in a new (opposite) quadrant. Animals were tested in 4 trials according to the same procedure 
previously described. The time of escape latency and the path described to reach the platform (distance 
swam) were recorded for each trial. 
 
3.6.7.2. Contextual fear conditioning (CFC) 
 The CFC test was conducted in white acrylic chambers with internal dimensions of 20 cm wide, 
16 cm deep and 20.5 cm high (MedAssociates), with a fixed light bulb mounted directly above the 
chamber to provide illumination. Each chamber contained a stainless steel shock grid floor inside a 
clear acrylic cylinder, where animals were placed. Animal were exposed to two probes, a context probe 
and a cue (light) probe, as previously described by Gu and colleagues (Gu et al. 2012). Mouse freezing 
behavior was monitored via video cameras and manually scored with the help of the behavioral scoring 
program Observador v.0.2.7 (University of Athens). The CFC procedures were conducted over 3 days. 
 Day 1: Mice were placed in the conditioning white chamber (Context A) and received 3 pairings 
between a light (20 s) and a co-terminating shock (1 s, ≈ 0.5 mA). The interval between pairings was 
set as 180 s, and the first tone presentation commended 180 s after the mouse was placed into the 
chamber. At the end of the three pairings, mice remained in the chamber for a further 30 s before 
being returned to their home cage. The chambers were cleaned with a 10% ethanol solution between 
each trial.  
 Day 2: for the context probe, animals were placed in the white chamber (Context A), where they 
were originally shocked, 24 h after the light-shock pairings. Freezing behavior was measured during 3 
min. Two hours later, animals were put in a modified version of the chamber (Context B) that was 
sheeted with a black plasticized cover that was previously sprayed with vanilla scent, in order to alter 
both spatial and odor references; the ventilation was not operated, and the experimenter wore a 
different style of gloves and lab coat. Again, freezing behavior was measured for 3 min. The freezing 
behavior state was defined as the complete privation of motion, for a minimum of 1 s. The chambers 
were cleaned between each trial with a 10% ethanol solution. 
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 Day 3: For the cue probe, test setting for Context B were maintained and animals were placed 
inside the chamber 24 h after the context probe. After 3 min, the light bulb was turned on during 20 s 
and freezing behavior was subsequently measured during 1 min.  
 
 
 
 
 
 
3.7. BrdU labeling in vivo 
 
 To assess the effect of AP2γ on the proliferation of fast-dividing progenitor cells, and 
comprehend its influence in the hippocampal neurogenic process of depressive-like animals, all animal 
groups were injected intraperitoneally with a thymidine analogous that is incorporated in the DNA during 
the S-phase (Taupin 2007), the bromodeoxyuridine (5-bromo-2’-deoxyuridine, BrdU; 50 mg/kg) at the 
end of all behavioral test, and sacrificed 24 h later. 
 
3.8. Fixation of mice brains and tissue processing 
 
 At the moment of sacrifice all animals were deeply anesthetized with a ketamine (75 mg/kg; 
Imalgene, USA) and medetomidine (1mg/kg; Syba, USA) solution, and then, different steps were 
performed depending on the purpose that we had for the sacrificed animal. 
 For vibratome sectioning: After anesthetized animals were transcardially perfused with cold 4% 
paraformaldehyde (PFA) in 0.1M PBS 1x solution. Brains were carefully removed from the skull and 
post fixed in 4% PFA for 12 h at 4ºC, rinsed in phosphate buffered saline (PBS) and stored in a 30% 
sucrose/PBS solution with 0.1% azide at 4ºC. Brains were coronal processed at the vibrotome (Leica VT 
1000S, Germany) with a thickness of 40 - 50 μm, extending over the entire length of the hippocampal 
formation. 
 For macrodissection: Animals that were destined to different tests like western-blots and 
quantitative real-time PCR were only perfused transcardially with a 0.9% saline solution, and brains 
were carefully removed, after decapitation, and different brain regions were macrodissected: PFC, 
+ 
 
Day 1 Day 2 
Context A 
Day 3 Day 2 
Context B 
2 h 
hJ
Figure 8. Schematic representation of the CFC protocol. 
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cortex, dorsal and ventral hippocampi, dorsal and ventral DG, SEZ, amygdala and cerebellum. The 
different brain regions were immediately stored at -80ºC until need for testing. 
  
3.9. Immunostainings  
 
Initially, the coronal vibratome processed sections were rinsed in PBS buffer prior to the 
staining procedure.  Eventual pretreatment of the sections is mentioned in the list of used antibodies 
Table 7. The coronal sections were then washed in PBS with 0.5% of Triton-X100 (Sigma; 3 times for 
15 min), since the antibodies used are intracellular markers. Afterwards, the blockage of non-specific 
binding was performed with PBS containing 10% fetal bovine serum (FBS, Biochrom, Germany). Then 
sections were incubated overnight at 4ºC with primary antibodies (specified in Table 7) diluted in PBS-
Triton with 10% FBS. The sections were washed in PBS-Triton several times. Secondary antibodies 
(Table 8), dissolved in PBS-Triton, were added and incubated for 2 h at RT. All coronal sections were 
stained with 4,6-diamidino-2-phenylindole (DAPI, 1:100, Invitrogen, USA) and mounted with immune-
mounting medium (Immu-Mount, Thermo Scientific). Finally, images were obtained at the confocal 
microscope (Olympus FluoViewTM FV1000, Germany) for further analyses. Solutions composition is 
described in Table 9. 
 
Table  7. List of primary antibodies 
 
Table  8. List of secondary antibodies 
 
Table  9. Solutions compositions 
Solution Composition 
PBS 1,3 M NaCl, 27 mM KCl, 15 mM KH2PO4, 83 mM NA2HPO4, pH 7.6 
PBS-T PBS 0.1%, Triton 0.5% 
PFA 4% PBS, 4%, pH 7.4 
Primary Antibody - Specie Working dilution Pretreatment Company 
DCX – Rabbit 1:100 
30 min HCl (2M) + 15 min in pre-
heated Cytrate buffer 
Abcam (UK) 
BrdU – Rat 1:50 
Secondary Antibody - Antigenicity Working dilution Company 
Alexa Fluor 568 – Anti-rabbit 1:1000 Invitrogen 
Alexa Fluor 488 – Anti-rat 1:1000 Invitrogen 
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3.10. Western blot 
 
DG of both adult constitutive and conditional AP2γ KO animal models were carefully 
macrodissected after decapitation. Tissue was weighted and homogenized in RIPA buffer [containing 50 
mM Tris HCl, 2 mM EDTA, 250 mM NaCl, 10 % glycerol, 1 mM PMSF protease inhibitors (Roche, 
Switzerland) and then sonicated (Sonics & Materials, USA) for 2 min. The samples were centrifuged for 
25 min at 10.000 rpm at 4°C. The protein concentration of the supernatant was determined using 
Bradford assay. Samples with equal amounts of protein, 30 μg, were analyzed using the following 
primary antibodies: beta-actin (Life Technologies, mouse, 1:200), AP2γ (Abcam, goat, 1:250), Pax6 
(Millipore, rabbit, 1:2000), Sox2 (Millipore, rabbit, 1:500) and Tbr2 (Abcam, rabbit, 1:500). Secondary 
antibodies were purchased from BioRad (anti-mouse, 1:10.000; anti-rabbit, 1:10.000) and Santa-Cruz 
Biotechnologies (anti-goat, 1:5000). Membranes were developed using ECL Clarity reagent (BioRad) 
and developed in ChemiDoc XRS System from BioRad. After developing, images were quantified using 
ImageLabTM Software (BioRad). 
 
3.11. Quantitative real-time PCR  
 
Reverse transcriptase-polymerase chain reaction (RT-PCR) is a method used to amplify 
complementary DNA (cDNA) copies of RNA using a reverse transcriptase. Sensitive and versatile, RT-
PCR is used to clone the 5’ and 3’ termini of mRNAs and to generate large cDNA libraries from very 
small amounts of mRNA. Quantitative real-time PCR (qRT-PCR) combine conventional PCR 
methodologies with a detection mechanism and quantification by fluorescence, allowing to monitor the 
progress of the PCR as it occurs (i.e., in real time). Using sequence-specific primers, the number of 
copies of a particular RNA sequence can be determined. By measuring the amount of amplified product 
at each stage during the PCR cycle, quantification is possible. The amount of cDNA is measured via 
fluorescent dyes that yield increasing fluorescent signal in direct proportion to the number of PCR 
product molecules generated.  In the present study, these techniques were used to analyze the 
expression levels of specific genes involved in epigenetic mechanisms. 
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3.11.1. RNA extraction  
 Dorsal and ventral DG of adult constitutive AP2γ KO animal model were carefully dissected 
after decapitation. The RNA from theses tissues was then separately extracted by the Direct-zol RNA 
mini prep kit following the instructions provided by the manufacture (Direct-zol RNA mini prep, Zymo 
Research, USA). 
 
3.11.2. cDNA transformation and quantitative Real-time PCR 
The cDNA synthesis was performed using iScriptTM cDNA Synthesis Kit (BioRad, USA). 1μg of 
purified RNA was used as template and volumes normalized with nuclease-free water. The complete 
reaction mix (RNA sample, 5x iScript reaction mix and iScript reverse transcriptase, Table 10) was 
incubated for 5 min at 25°C followed by 30 min at 42°C and for final 5 min at 85°C, in a thermal 
cycler (Applied Biosystems, USA).  
 
Table  10. cDNA mix composition 
Components Volume per Reaction 
5x iScript reaction mix 4 µL 
iScript reverse transcriptase 1 µL 
Nuclease-free water x µL 
RNA sample x µL 
Total volume 20 µL 
 
Differences in gene expression were assessed by qRT-PCR. For quantitative gene expression 
analysis, the cDNA was subject to PCR amplification using Eva Green technology (Ssofast Evagreen 
supermix, BioRad) on the Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems, USA) 
in order to obtain the real-time detection of PCR products.  Reaction solution was obtained with 5 µL of 
Ssofas Evagreen supermix, plus 10 µM from each primer, forward and reverse (Table 11). As template 
1 µL of cDNA was used. The cycling conditions applying in this procedure were 30 s at 95°C for the 
enzyme activation, followed by 40 cycles of 5 s at 95°C for denaturation, 5 s at 60°C for annealing and 
5 s at 72°C for extension step (Table 12). As reference gene Hspcb was used. The fold increase was 
determined using the 2-ΔΔCt (Livak) relative quantification method (Livak and Schmittgen 2001; Cardozo 
et al. 2012). 
 
 
 
 
49 
Table 11. List of PCR primers used to amplify genes associated with epigenetic mechanisms 
 
Table 12. PCR mix composition and reaction conditions 
Mix Components Volume (μL) cDNA template PCR conditions 
Evagreen Supermix 5 
1 µL 
95°C, 30 s 
95°C, 5 s 
60°C, 5 s 
72°C, 5 s 
Primer Forward 0.5 
Primer Reverse 0.5 
Nuclease-Free Water 3 
 
3.12. Data analysis 
 
 Statistical analysis was performed using IBM SPSS Statistics v.22 (IBM Com, USA) and graph’s 
representation using GraphPad Prism v.6 (GraphPad Software, La Jolla, USA).  
In order to compare the mean values for two groups, a two-tailed independent-sample t-test 
was applied. If an evaluation along time was required, a repeated measures ANOVA was performed. On 
the other hand, statistical evaluation for animal behavior tests and histological analysis for the adult 
mice, a two-way ANOVA was used to compare the interaction between two variables. Moreover, when 
we analyzed the corticosterone levels (nadir and zenith) presented in the animals’ serum was used a 
Paired t-test. 
Normality was measured using the Kolmogorov-Smirnov and Shapiro-Wilk statistical tests and 
taking into account the respective histograms and measures of skewness and kurtosis. Equality of 
variances and Sphericity were measured using the Levene’s and Mauchly’s tests, respectively, and was 
assumed when p>0.05. Multiple comparisons between groups were accomplished through the 
Bonferroni statistical test.  
Gene Primer sequence Product size (bp) 
HSPCB 
Forward 5’-GCTGGCTGAGGACAAGGAGA -3’ 
Reverse 5’-CGTCGGTTAGTGGAATCTTCATG-3’ 
93 
DNMT3a 
 
Forward 5’- CCTGCAATGACCTCTCCATT -3’ 
Reverse 5’-  CAGGAGGCGGTAGAACTCAA-3’ 
89 
DNMT3b 
Forward 5’- TGGTGATTGGTGGAAGCC -3’ 
Reverse 5’-  AATGGACGGTTGTCGCC -3’ 
145 
TET1 
Forward 5’- CCATTCTCACAAGGACATTCACA -3’ 
Reverse 5’- GCAGGACGTGGAGTTGTTCA -3’ 
116 
TET2 
Forward 5’- GCCATTCTCAGGAGTCACTGC -3’ 
Reverse 5’- ACTTCTCGATTGTCTTCTCTATTGAGG -3’ 
120 
TET3 
Forward 5’- GGTCACAGCCTGCATGGACT-3’ 
Reverse 5’- AGCGATTGTCTTCCTTGGTCAG -3’ 
104 
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 Values were accepted as significant if the p-value was higher than 0.05 and all results were 
expressed as group mean ± SEM (standard error of the mean). Effect size was calculated using the 
Cohen’s d or η2partial.  
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3.13. Experimental design 
 
 
 
 
 
Figure 9. Experimental design 
(A) Timeline of the experimental procedures 
performed to assess the impact of AP2γ 
deletion in the developmental milestones; (B) 
Timeline of the experimental procedures 
performed to study the impact of the 
transcription factor AP2γ on the behavior of 
juvenile mice; (C, D) Functional impact of the 
transcription factor AP2γ in Depression, in 
both constitutive and conditional AP2γ KO 
models; (E) Histological procedures 
performed in this study. 
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4. RESULTS 
4.1. Functional impact of the transcription factor AP2γ in the neurodevelopment  
 
4.1.1. Developmental milestones assessment 
 The results of the different behavioral parameters analyzed are presented as the average of 
three independent experimental sets and summarized in Figure 10 and Table 13-14 (presented as the 
average of day of mature response within the 21 days of the milestones protocol).  
 
 Somatic Parameters 
 When evaluating the general body weight and anogenital distance throughout the 21 days of 
the milestones protocol no differences where found between genotypes (Figure 10A-B and Table 13). 
Another hallmark for somatic development is the day of eye opening and for that we had constitutively 
registered the state of eyes opening until both eyes were found opened. We found that AP2γ+/- animals 
opened both of their eyes around one day earlier than the WT group (AP2γ+/- animals group opened both 
of their eyes around PND11 and the WT group around PND12) (Figure 10C and Table 13). 
Table 13. Summary of body weight and anogenital distance throughout the 21 days of the milestones 
protocol and eye opening day 
 Data presented as mean ± SEM. In grey shading is the somatic parameter where differences between groups were 
observed. 
Milestones test WT AP2γ+/- 
Statistical test, significance, 
effect size 
Weight 
Day 1 1.62 ± 0.07 1.57 ± 0.09 
F(1,16)=0.32, p=0.58, η2partial=0.019 
Day 2 1.83 ± 0,10 1,97 ± 0.17 
Day 3 2.16 ±  0.14 2,37 ± 0.14 
Day 4 2.59 ± 0.19 2,79 ± 0.16 
Day 5 3.07 ± 0.25 3,20 ± 0.15 
Day 6 3.56 ± 0.27 7,60 ± 0.14 
Day 7 4,03 ± 0.45 4,36 ± 0.19 
Day 8 4,58 ± 0.47 5,00 ± 0.14 
Day 9 5,16 ± 0,46 5,43 ± 0.14 
Day 10 5,81 ± 0,38 5,97 ± 0.13 
Day 11 6,43 ± 0.36 6,59 ± 0.11 
Day 12 7,00 ± 0.42 7,20 ± 0.12 
Day 13 7,41 ± 0.42 7,66 ± 0.14 
Day 14 8,02 ± 0.35 8,08 ± 0.15 
Day 15 8,35 ± 0.32 8,41 ± 0.03 
Day 16 8,52 ± 0.36 8,58 ± 0.15 
Day 17 8,62 ± 0.40 8,58 ± 0.14 
Day 18 8,60 ± 0.46 8,73 ± 0.13 
 Day 19 8,60 ± 0.50 8,89 ± 0.12 
 Day 20 8,68 ± 0.50 9,09 ± 0.15 
 Day 21 8,99 ± 0.53 9,22 ± 0.16 
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 Day 3 0.75 ± 0.07 0.81 ± 0.08  
Normalized 
Anogenital 
Distance 
(AD/Weight) 
Day 4 0.80 ± 0.07 0.80 ± 0.1 
F(1,16)=0.87, p=0.37, η2partial=0.051 
Day 5 0.72 ± 0.05 0.82 ± 0.05 
Day 6 0.71 ± 0.06 0.73 ± 0.04 
Day 7 0.76 ± 0.11 0.73 ± 0.03 
Day 8 0.76 ± 0.09 0.73 ± 0.25 
Day 9 0.72 ± 0.08 0.73 ± 0.02 
Day 10 0.70 ± 0.03 0.76 ± 0.02 
Day 11 0.70 ± 0.22 0.74 ± 0.15 
Day 12 0.65 ± 0.02 0.67 ± 0.01 
Day 13 0.65 ± 0.02 0.67 ± 0.01 
Day 14 0.64 ± 0.02 0.65 ± 0.01 
Day 15 0.64 ± 0.02 0.68 ± 0.01 
Day 16 0.64 ± 0.02 0.68 ± 0.01 
Day 17 0.64 ± 0.02 0.70 ± 0.01 
Day 18 0.67 ± 0.03 0.71 ± 0.01 
Day 19 0.69 ± 0.03 0.71 ± 0.01 
Day 20 0.72 ± 0.02 0.72 ± 0.01 
 Day 21 0.72 ± 0.02 0.72 ± 0.01 
Eye opening 12.38 ± 0.18 11.33 ± 0.17 t(15)= 4.22, p= 0.0007, Cohen’s d= 2.06 
 
Neurobiological reflexes 
 In the parameters examined to evaluate the physical maturation of motor reflexes, coordination 
and strength needed for motor skills no major differences were observed in surface righting, cliff 
aversion and air righting tests (Figure 10D, F-G and Table 14). However, in the negative geotaxis test 
the AP2γ+/- group seems to acquire the mature response later than the WT group, with the mature 
response of the first group around 1.3 days later than the WT (Figure 10E and Table 14).  
 Regarding the evaluation of postural reflex, meaning the posture that animals present when 
they are gently shacked, no impairments were found between groups, with all animals exhibiting the 
mature response around PND9 (Figure 10H and Table 14). The same results were observed for the 
more specific tests used to assess reflexes, namely rooting, ear twitch, auditory startle and grasping 
where all animals regardless of genotype achieved a mature response around PND7, PND16, PND9 
and PND8 respectively (Figure 10I-L and Table 14).  
 In the wire suspension test, which is used for strength measurements, we found that AP2γ+/- 
animals acquire the mature response earlier than the WT group, appearing it around 2.3 days later 
than the WT group (Figure 10M and Table 14). As for the tests specifically used for motor coordination 
assessment, namely walking and open field, no differences were found between genotypes, with an 
average of maturation day around PND10 for walking and PND8 for open field (Figure 10N-O and Table 
14). 
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Figure 10. The constitutive deletion of one allele of AP2γ impact on the milestones development and 
maturity. 
Using a set of established tests used to evaluate both somatic and neurologic parameters acquisition, from PND0 until 
PND21, AP2γ+/- animals were found to have an anticipated eye opening (C) day, and also an anticipated mature response in 
the strength test wire suspension (M). Through the milestones protocol it was also possible to unveil a delayed mature 
response of the AP2γ+/- group in the negative geotaxis test (E). All tests are presented as the average day of mature activity 
(nWT= 9; nAP2γ+/-=9. Data presented as mean ± SEM, *<0.05; **<0.01; ***p<0.001 
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Through the homing test (Figure 10P and Table 14), which was performed at PND12, it was 
not possible to observe any major impairment between groups, suggesting that there were no olfactory 
and motor deficits in these animals, in both genotypes.  
 
Table 14. Summary of the average days of mature response obtained in each genotype during the 
neurobiological reflexes milestones assessment.  
Data presented as mean ± SEM. In grey shading are the tests where it was observable differences between groups. 
Milestones test WT AP2γ+/- 
Statistical test, significance, 
effect size 
Surface righting 5.9 ± 0.44 7.0 ± 0.49 t(20)= 1.79, p=0.09, Cohen’s d= 0.76 
Negative geotaxis 8.0 ± 0.22 9.3 ± 0.37 t(13)= 2.83, p=0.01, Cohen’s d= 1.49 
Cliff aversion 7.7 ± 0.61 6.0 ± 0.58 t(13)= 2.83, p=0.01, Cohen’s d= 1.09 
Air righting 11.9 ± 0.73 10.8 ± 0.60 t(13)= 2.83, p=0.01, Cohen’s d= 0.55 
Postural reflex 9.4 ± 0.80 8.6 ± 0.34 t(13)= 2.83, p=0.01, Cohen’s d= 0.47 
Rooting 6.9 ± 0.56 7.6 ± 0.47 t(13)= 2.83, p=0.01, Cohen’s d= 0.43 
Ear twitch 8.4 ± 0.60 9.0 ± 0.33 t(13)= 2.83, p=0.01, Cohen’s d= 0.46 
Auditory startle 7.6 ± 0.26 7.6 ± 0.38 t(13)= 2.83, p=0.01, Cohen’s d= 0 
Grasping 16.4 ± 0.75 15.4 ± 0.75 t(13)= 2.83, p=0.01, Cohen’s d= 0.43 
Wire suspension 13.1 ± 0.58 10.8 ± 0.37 t(13)= 2.83, p=0.01, Cohen’s d= 1.73 
Walking 10.3 ± 0.62 10.1 ± 0.58 t(13)= 2.83, p=0.01, Cohen’s d= 0.11 
Open field 8.4 ± 0.26 8.1 ± 0.13 t(13)= 2.83, p=0.01, Cohen’s d= 0.43 
Homing 
Trial 1 6.89 ± 0.44 6.89 ± 1.32 
F(1,16)=0.11, p=0.74, η2partial= 0.007 Trial 2 6.33 ± 1.12 6.89 ± 1.12 
Trial 3 5.22 ± 1.57 5.78 ± 1.57 
 
4.1.2. The transcription factor AP2γ impact on behavior of juvenile mice 
 To understand if the transcription factor AP2γ could have an impact on the juvenile behavior, 
we used a set of established behavioral tests in animals with age between PND25 and PND31. We 
started the juvenile behavior characterization by evaluating if AP2γ transcription factor has an impact on 
anxious-like behavior through the OF test. Although it is not described as a classical test for anxiety, the 
OF test can also be used as an indicator of possible anxious-like behavioral states of rodents, by 
evaluating the ratio of time spent and distanced traveled in the center versus the periphery of the arena 
(Prut and Belzung 2003). With this test, it was possible to observe that the AP2γ+/- mice traveled lower 
distances (Figure 11A and Table 15) and spent less time in the center of the arena (Figure 11B and 
Table 15) suggesting higher anxiety levels when compared to the WT group. Furthermore, it was 
possible to evaluate locomotor activity, measured as the average velocity of mice during the execution 
of the test, which did not differ between WT and AP2γ+/- mice (Figure 11C and Table 15), thus validating 
subsequent behavioral testing that relay on locomotor activity. Also through the OF test, we observed 
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that the AP2γ+/- mice were less willing to explore the arena as they showed higher percentage of time in 
resting state (Figure 11D and Table 15) and presented a lower total distance traveled (Figure 11E and 
Table 15). Then we assessed if in basal conditions there are any signs of susceptibility to behavioral 
despair, through the TST. We did not found any differences between the two groups in the percentage 
of time that mice stay immobile during the test (Figure 11F and Table 15), suggesting the absence of 
depressive-like symptoms in AP2γ+/-  juvenile mice. Also in the splash test we did not found differences 
between groups in the time that the animals spent grooming (Figure 11G and Table 15) after applying a 
sucrose solution to their coat, indicating that AP2γ+/- juvenile mice do not present core alterations 
regarding motivational self-care.  
 
Table  15. Statistical analysis of the juvenile behavior tests.  
Data presented as mean ± SEM. In grey shading are the behavioral tests where it was possible to observe differences 
between groups. 
 
 
  
Behavioral Test WT AP2γ+/- 
Statistical test, significance, 
effect size 
OF 
Distance traveled center (%) 3.152 ± 0.60 0.77 ± 0.55 t(19)= 2.29, p=0.03, Cohen’s d= 1.35 
Time in center (%) 6.651 ± 1.34 3.01 ± 0.98 t(19)= 2.06, p=0.06, Cohen’s d= 1.26 
Average velocity (cm.s-1) 56.95 ± 1.73 60.10  ± 2.34 t(19)= 1.01, p=0.28, Cohen’s d= 0.82 
Time in resting state (%) 82.87 ± 0.94 86.28 ± 1.04 t(19)= 0.18, p=0.03, Cohen’s d= 1.13 
Total distance (cm) 3799 ± 514.3 1645 ± 589.7 t(19)= 2.73, p=0.01, Cohen’s d= 1.19 
TST Immobility time (%) 51.01 ± 5.88 49.70 ± 4.53 t(19)= 0.18, p=0.86, Cohen’s d= 0.066 
Splash 
test 
Time grooming (%) 76.86 ± 3.19 78.00 ± 5.67 t(10)= 0.19, p=0.85, Cohen’s d= 0.106 
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4.1.3. The transcription factor AP2γ impact on hippocampal glutamatergic 
neurogenesis in juvenile mice 
 In previous studies from the group hippocampal dentate gyrus (DG) cell proliferation and 
glutamatergic neurogenesis in the brain of AP2γ+/- adult mice was already characterized. However, it 
was not analyzed if these effects in the adult mice promoted by deletion of AP2γ are indeed specifically 
observed at adult stages, or if during the developmental and maturity stages there is already an effect of 
the constitutive deletion of one allele of the AP2γ gene in the hippocampal neurogenesis.  
To comprehend if the reduced expression of AP2γ could have already an impact on 
hippocampal glutamatergic neurogenesis during development and maturity stages, we injected juvenile 
animals with BrdU and sacrificed them 24h later (at PND31), allowing us, through immunostaining, to 
assess the proliferation of progenitor cells and newborn neurons (neuroblasts expressing doublecortin – 
DCX). Analysis of total cell proliferation in the DG of WT and AP2γ+/- animals revealed no significant 
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Figure 11. The impact of the constitutive deletion of one allele of AP2γ in the emotional and mood 
behavioral dimension of juvenile mice. 
Using a set of established behavioral tests, it was possible to assess anxiety, mood, and motivational care in juvenile mice 
from PND25 to PND31. Through the OF test we observed that AP2γ+/- showed a higher anxiety level, since they traveled 
lower distances and spent less time in the center of the arena (A-B). No locomotor deficits were found between groups 
(C), but the AP2γ+/- mice were less willing to explore the arena since they spent an higher period in resting state (D) and 
had a lower distance traveled (E). In the TST (F) and in the Splash test (G) no differences were found between groups 
suggesting that in basal state AP2γ+/- mice do not display depressive-like symptoms. (OF and TST: nWT= 12 ; nAP2γ+/-= 9 ; 
Splash test: nWT= 7; nAP2γ+/-= 5. Data presented as mean ± SEM, *p<0.05). 
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differences between groups, although the proliferation values of AP2γ+/- animals were slightly reduced 
(Figure 12B, Table 16). 
In addition, we analyzed proliferation of neuroblasts with double staining for BrdU and DCX, 
revealing a significant difference between WT and AP2γ+/- animals. In AP2γ+/- mice, a decreased 
proliferation of neuroblasts was observed as shown by the reduced number of double-positive 
BrdU/DCX cells, when compared to the WT control group (Figure 12C, Table 16). 
These differences in neuronal proliferation observed in juvenile animals with constitutive 
deletion of one allele of AP2γ in comparison to the WT animals confirm the involvement of this 
transcription factor in the modulation of post-natal glutamatergic neurogenesis (in the healthy brain) 
already during development and maturity of these animals. 
 
Table 16. Statistical analysis of the post-natal glutamatergic neurogenesis of juvenile animals.  
Data presented as mean ± SEM. In grey shading is the cell-count where it was possible to observe differences between 
groups. 
Markers WT AP2γ 
Statistical test, significance, 
effect size 
BrdU single-positive cells 194.3 ± 15.42 123.1 ± 22.27 t(3)= 2.63, p=0.12, Cohen’s d= 2.63 
BrdU/DCX double positive cells 123.6 ± 15.83 49.27 ± 6.94 t(3)= 4.30, p=0.05, Cohen’s d= 4.30 
 
 
Hippocampal glutamatergic neurogenesis in juvenile mice 
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4.2. Functional impact of the transcription factor AP2γ in Depression 
 
4.2.1. Validation of the uCMS model of depression 
 In order to validate the uCMS protocol implemented in this study we used two major measures 
to control its efficacy. Throughout the six weeks of the uCMS protocol we controlled the animals’ weight 
weekly to perceive if the animals from control and uCMS groups were showing different body mass 
gains. It was possible to observe in both constitutive (Figure 13A and Table 17) and conditional (Figure 
13A and Table 18) KO animal models that the uCMS protocol was producing different effects when 
comparing the control and uCMS groups, in which the first group was gaining and maintaining the 
gained weight, and the second one was first loosing weight and maintaining the weight lost throughout 
the six weeks of the stress protocol. The genotype variable did not impact the weight gain or loss in 
both animal models (Supplementary figures 1 and 2). Since this gain/loss weight measure is not 
sufficient to fully understand and validate if the uCMS protocol was efficient in inducing core symptoms 
of depression, we proceed to molecular analysis.  
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Figure 12. Impact of the constitutive deletion of one allele of AP2γ in the post-natal hippocampal glutamatergic 
neurogenesis of juvenile animals. 
Hippocampal sections were immunostained for BrdU and DCX (A). Immature neurons (neuroblasts) are identified as BrdU 
and DCX double-positive cells (white arrows), whereas the remaining proliferative cells are single-BrdU positive cells (yellow 
arrow). Global proliferation (total BrdU positive cells/per area of DG) have been determined (B) as well as the proliferation 
of neuroblasts (total double positive BrdU/DCX cells/per area of DG) in the complete DG (C). (nWT = 3; nAP2γ+/- = 3; Data 
presented as mean ± SEM, *p<0.05). 
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uCMS exposure is known to disrupt the hypothalamic-pituitary-adrenal (HPA) axis (Ottenweller 
et al. 1994), and therefore the measurement of corticosterone (produced by the adrenals) levels in 
blood provides a correlate of the stress-level in the tested animals (Sousa et al. 1998; Ventura-Silva et 
al. 2013; Patricio et al. 2015). Knowing that control animals display a corticosterone peak at diurnal 
zenith (night time, peak levels) (D'Agostino et al. 1982), which is affected in animals exposed to chronic 
stress, we measured the levels of corticosterone at the end of the uCMS protocol (6th week) both at 
nadir (day time, basal) and zenith. It was possible to notice that both constitutive (Figure 13B and Table 
17) and conditional (Figure 14B and Table 18) control groups maintained a normal circadian rhythm of 
corticosterone secretion, since there is a significantly peak of corticosterone at the zenith time-point. 
The uCMS exposed-groups showed a disruption of the HPA axis by presenting a significantly higher 
nadir levels of corticosterone than the control groups, and no circadian regulation, as there are no 
differences between nadir and zenith in both constitutive (Figure 13B and Table 17) and conditional 
(Figure 14B and Table 18) uCMS groups. 
 
 
 
 
 
Validation of the uCMS model of depression  in the constitutive AP2γ KO animal model 
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Figure 13. Validation of the uCMS model of depression in the constitutive AP2γ KO animal model. 
Using the percentage of weight gain (A) throughout the six weeks of the uCMS protocol, and the corticosterone (B) 
levels measured in the animals’ serum between 8:00 and 9:00 (basal levels; nadir) and between 20:00 and 21:00 
(peak levels; zenith) at the 6th week of the uCMS protocol it was possible to confirm its efficacy. (Weight gain: nControls=15, 
nuCMS=15; Corticosterone levels: nWT=5, nAP2γ+/-=4, nWT=5, nAP2γ+/-=4; Data presented as mean ± SEM; **p<0.01; 
****p<0.0001). 
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Table 17. Statistical analysis of the parameters used to validate the uCMS protocol in the constitutive KO 
animal model.  
Data presented as mean ± SEM. In grey shading are the tests were it was observable differences between the variables. 
Abbreviations: Week(W). 
 
 
 
 
Validation of the uCMS model of depression in the conditional AP2γ KO animal model 
Test 
Control uCMS 
Statistical test, significance, effect size 
WT AP2γ+/- WT AP2γ+/- 
Weight 
W1 -1.87 ± 0.51 -7.6 ± 0.39 
F(1,28)=2.15, p< 0.0001, 
η2partial= 0.528 
W2 1.33 ± 0.91 -4.4 ± 0.84 
W3 6.73 ± 1.35 -2.27 ± 1.44 
W4 5.07 ± 1.27 -3.6 ± 1.57 
W5 10.40 ± 1.30 1.47 ± 1.67 
W6 10.47 ± 1.40 -2.40 ± 1.59 
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Figure 14. Validation of the uCMS model of depression in the conditional AP2γ KO animal model. 
Using the percentage of weight gain (A) throughout the six weeks of the uCMS protocol, and the corticosterone (B) levels 
measured in the animals’ serum between 8:00 and 9:00 (basal levels; nadir) and between 20:00 and 21:00 (peak levels; 
zenith) it was possible to confirm the efficacy of the uCMS protocol. [Weigh gain: nControls=17, n uCMS=18; Corticosterone levels: 
Controls (n cAP2γ+/+=8, ncAP2γ-/-=3), uCMS (n cAP2γ+/+=9, nAP2γ-/-=4); Data presented as mean ± SEM; *p<0.05; **p<0.01; ****p<0.0001]. 
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Table 18. Statistical analysis of the parameters used to validate the uCMS protocol in the conditional KO 
animal model.  
Data presented as mean ± SEM. In grey shading are the tests were it was observable differences between the variables. 
Abbreviations: Week(W). 
 
4.2.2. Assessment of the behavior dimensions affected by the uCMS protocol 
 In previous studies from the group it was already confirmed the importance of AP2γ 
transcription factor in the modulation of adult hippocampal glutamatergic neurogenesis, playing an 
important role in hippocampal proliferation and neuronal differentiation through reciprocal interactions 
with transcriptional regulators of glutamatergic neurogenesis (Mateus-Pinheiro et al. 2016). In this 
master thesis work, once again, we demonstrated the modulatory action of AP2γ on glutamatergic 
neurogenesis through the results in juvenile mice (Figure 12). Taking this in consideration, we aimed to 
assess if AP2γ could have a functional role in neurogenesis-related neuropathological contexts, namely 
depression. Therefore, we submitted both constitutive and conditional AP2γ KO animal models to an 
uCMS protocol during 6 weeks and assessed the impact of chronic stress exposure using different 
behavioral tests and paradigms. 
 uCMS exposure typically produces deficits in three behavioral dimensions that are commonly 
affected in depression – anxiety, mood and cognition (Bessa et al. 2009b). Thus, a multidimensional 
behavioral analysis was performed in this work. We started by assessing the anxiety dimension through 
the OF and the EPM tests. In the first behavioral test to evaluate anxiety-like traits we found similar 
results in both constitutive and conditional AP2γ KO animal models. It was possible to observe in both 
models a susceptibility of control AP2γ KO groups (AP2γ+/- and cAP2γ-/-) to display anxious-like behavior 
Test 
Control uCMS 
Statistical test, significance, effect size 
cAP2γ+/+ cAP2γ-/- cAP2γ+/+ cAP2γ-/- 
Weight 
W1 0.09 ± 0.67 -4.13 ± 0.70 
F(1,36)=2.98, p< 0.0001, 
η2partial= 0.63 
W2 2.85 ± 0.79 -2.64 ± 0.82 
W3 3.85 ± 0.79 -4.27 ± 0.66 
W4 8.67 ± 1.17 -1.73 ± 0.66 
W5 8.04 ± 1.06 -3.68 ± 0.66 
W6 8.06 ± 1.19 -0.52 ± 0.81 
Corticosterone 
levels 
Nadir 
(N) 
23.79± 
6.72 
9.03 ± 
1.25 
51.06 ± 
10.94 
45.69 ± 
10.41 
Control 
cAP2γ+/+ 
NControl 
cAP2γ+/+/ 
/NuCMS  
cAP2γ+/+ 
Control  
cAP2γ-/- 
NControl 
cAP2γ-/-/ 
/NuCMS  
cAP2γ-/- 
uCMS 
cAP2γ+/+ 
uCMS  
cAP2γ-/- 
t7=3.93   
p= .006 
Cohen’s 
d=2.19  
t14=2.36   
p= 0.03 
Cohen’s 
d=1.18 
t4= 3.32 
p= 0.03 
Cohen’s 
d=2.67 
76=2.8   
p=0.03 
Cohen’s 
d=2.35 
t13=1.99, 
p=0.07, 
Cohen’s 
d=1.03 
t3=1.84, 
p=0.16, 
Cohen’s 
d=1.56 
Zenith 
(Z) 
74.17± 
9.31 
72.09 ± 
18.95 
87.38 ± 
18.25 
54.81 ± 
29.79 
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since both groups show a lower distance traveled in the center of the OF arena (Figure 15A and 16A, 
Table 19 and 20). Although not reaching statistical difference in the conditional KO animal model, it 
was possible to note also that the control KO animals have a lower percentage of time spent in the 
center of the arena when compared to the respective control groups (WT and cAP2γ+/+). In the 
constitutive AP2γ KO animal model it was not possible to observe statistical differences between control 
and uCMS groups. However, in this model we observed a tendency of WT uCMS animals to travel 
smaller distances (Figure 15A, Table 19), and to spend less time in the center of the arena (Figure 
15B, Table 19) when compared to the control WT group. In the conditional AP2γ KO model, statistical 
differences were found between the control cAP2γ+/+ and the uCMS cAP2γ+/+ groups in the distance 
traveled and in the percentage of  time spent in the center of the arena (Figure 16AB, Table 20), 
suggesting increased anxiety levels upon stress exposure. In both models it was not possible to observe 
differences between the control and the uCMS AP2γ KO groups (AP2γ+/- and cAP2γ-/-) (Figure 15AB and 
16AB, Table 19 and 20). Furthermore, through the OF test we assessed locomotor activity, measured 
as the average velocity (Figure 15C and 16C, Table 19 and 20), and in both animal models no 
differences were found between the groups, thus validating subsequent behavioral tests that relay on 
locomotor activity. 
In the EPM test no predisposition to an anxious-like behavior was found between the control 
groups, since in both animal models no differences were unveiled between the control groups (control 
WT/AP2γ+/- and control cAP2γ+/+/cAP2γ-/-) (Figure 15D and 16D, Table 19 and 20). However, WT and 
AP2γ+/- uCMS groups, from the constitutive model, spent a higher percentage of time in the closed 
arms, when compared to the respective control situations (Figure 15D, Table 19). More so, the 
conditional cAP2γ+/+ uCMS group showed an higher percentage of time spent in the closed arms of the 
EPM apparatus, when compared to the cAP2γ+/+ control group (Figure 16D, Table 20).  
Considering the behavioral output provided together by the OF and the EPM tests, the 
employed uCMS protocol had impact on the anxiety levels of both mice strains analyzed. Notably, in 
these two behavioral tests, different trends regarding the control situations were observed, since in the 
OF test we could evidentiate an anxious-like behavior in the AP2γ KO groups, which was not the case in 
the EPM test. 
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Constitutive AP2γ KO animal model – AP2γ impact in the anxiety and mood dimensions of 
depression  
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Figure 15. Impact of the constitutive deletion of one allele of AP2γ in the anxiety and mood behavioral 
dimensions of depression. 
After 6 weeks of uCMS, anxiety-like signs [Distance traveled in center arena (A) and Time in center (B)] and locomotor 
activity were assessed in the OF test. Anxiety behavior was determined in the EPM test (D), and learned helplessness was 
evaluated by the FST. (Control: nWT= 8, nAP2γ+/-= 7 ; uCMS: nWT= 8, nAP2γ+/-=7; Data presented as mean ± SEM; *p<0.05). 
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Table 19. Statistical analysis of the behavioral tests used to evaluate anxiety-like behavior and mood of the 
constitutive AP2γ KO animal model.  
Data presented as mean ± SEM. In grey shading are the tests were it was observable differences between the variables 
 
 
We next performed the FST and the TST to assess learned helplessness, a known depressive-
like symptom. With this two tests it was possible to evaluate the depressive-like state of the animals in 
behavioral paradigms. Although we did not perform the TST in the constitutive AP2γ KO animal model, 
it was possible to see in both models similar results in the FST. Here, both animal models displayed, no 
kind of predisposition to depressive-like behavior in the control groups, and chronic stress exposure 
impacted the WT and cAP2γ+/+ uCMS groups in the constitutive and conditional AP2γ models, since the 
immobility time is significantly higher in these groups, when compared to the respective control groups 
(Figure 15E and 16E, Table 19 and 20). However, this difference between control and uCMS was not 
obtained in both KO groups (AP2γ+/- and cAP2γ-/-; Figure 15E and 16E, Table 19 and 20). In the TST 
(Figure 16F, Table 20), which was only performed in the conditional AP2γ KO animal model, we did 
obtain the same conclusions, since an increased immobility time between the uCMS and control 
cAP2γ+/+ groups was observed. We did not observe differences between the KO groups from both 
constitutive and conditional animal models (AP2γ+/- and cAP2γ-/-). 
  
Test 
Control uCMS Statistical test, significance, 
effect size WT AP2γ+/- WT AP2γ+/- 
OF 
Distance traveled 
center 
3.24 ± 0.57 1.33 ±1.36 1.56 ± 0.83 0.77 ± 0.38 
Interaction Genotype vs uCMS: 
F(1,16)= 0.95, p=0.34, η2partial= 0.06 
Interaction Control vs uCMS: 
F(1,16)= 3.77, p=0.07, η2partial= 0.19 
Interaction WT vs AP2γ+/-: 
F(1,16)= 5,48, p=0.03, η2partial= 0.26 
Time in center 1.74 ± 0.33 0.69 ± 0.40 0.97 ± 0.31 0.47 ± 0.17 
Interaction Genotype vs uCMS: 
F(1,16)= 1.39, p=0.26, η2partial=0.08  
Interaction Control vs uCMS: 
F(1,16)= 4.50, p=0.04, η2partial=0.22  
Interaction WT vs AP2γ+/-: 
F(1,16)= 10.85, p=0.004, η2partial= 0.40 
Average velocity 
WT AP2γ+/- 
t27= 0.17, p=0.68, Cohen’s d= 0.25 63.45 ± 3.06 62.70 ± 2.99 
EPM 
Time in closed 
arms 
53.49 ± 6.88 51.68 ± 6.70 70.09 ± 4,70 72.02 ± 5.43 
Interaction Genotype vs uCMS: 
F(1,21)= 0.21, p=0.65, η2partial= 0.01 
Interaction Control vs uCMS: 
F(1,21)= 20.10, p<0.0001, η2partial= 0.49 
Interaction WT vs AP2γ+/-: 
F(1,21)= 0.0002, p=0.99, η2partial= 0.001 
FST 
Time of 
immobility 
44. 26 ± 3.07 45.63 ± 7.2 66.27 ± 5.71 48.23 ± 5.75 
Interaction Genotype vs uCMS: 
F(1,17)= 4.12, p=0.06, η2partial= 0.20 
Interaction Control vs uCMS: 
F(1,17)= 6.62, p=0.02, η2partial= 0.28 
Interaction WT vs AP2γ+/-: 
F(1,17)= 3.04, p=0.09, η2partial= 0.152 
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Conditional AP2γ KO animal model – AP2γ impact in the anxiety and mood dimensions of 
depression 
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Figure 16. Impact of the conditional deletion of one allele of AP2γ in the anxiety and mood behavioral 
dimensions of depression. 
After 6 weeks of uCMS, anxiety-like signs [Distance traveled in center arena (A) and Time in center (B)] and locomotor activity 
were assessed in the OF test. Anxiety behavior was determined in the EPM test (D), and learned helplessness was evaluated by 
the FST. Control: ncAP2γ+/+= 8, ncAP2γ-/-= 7 ; uCMS: ncAP2γ+/+= 8, ncAP2γ-/-=7; Data presented as mean ± SEM; *p<0.05; **p<0.01. 
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Table 20. Statistical analysis of the behavioral tests used to evaluate anxiety and mood dimension of the 
conditional AP2γ KO animal model.  
Data presented as mean ± SEM. In grey shading are the tests were it was observable the differences between variable 
 
Next, we assessed the impact of AP2γ deletion in different cognitive domains in both 
constitutive and conditional animal models. We first performed different water maze paradigms, 
beginning with the evaluation of the working memory task, in which we observed the detrimental effects 
of chronic stress exposure in the uCMS WT animals, since this group showed a significant delay to 
reach the platform along the four trials of testing, when compared to the respective WT control group 
(Figure 17A, Table 21). However, it was not possible to see the same effect of chronic stress exposures 
on the AP2γ+/- animals, as both WT and AP2γ+/- control groups presented similar performances in this 
behavioral paradigm. In the conditional AP2γ model, no differences were found in the working memory 
task between genotypes, and stress exposure did not induce any deleterious on the conditional KO 
animals (Figure 18A, Table 22). In the spatial reference memory task, which relies on the integrity of 
hippocampal function, the control AP2γ KO groups (AP2γ+/- and cAP2γ-/-) did not display reference 
memory deficits in comparison to the respective control WT groups (WT and cAP2γ+/+) (Figure 17B and 
Test 
Control uCMS Statistical test, significance, 
effect size cAP2γ+/+ cAP2γ-/- cAP2γ+/+ cAP2γ-/- 
OF 
Distance traveled 
center 7.05 ± 0.97 1.01 ± 0.75 1.85 ± 0.51 1.26 ± 0.55 
Interaction Genotype vs uCMS: 
F(1,36)= 6.1, p=0.018, η2partial= 0.15 
Interaction Control vs uCMS: 
F(1,36)= 5.04, p=0.03, η2partial= 0.12 
Interaction WT vs AP2γ+/-: 
F(1,36)= 8.98, p=0.005, η2partial= 0.20 
Time in center 2.26 ± 1.06 0.77 ± 0.36 0.87 ± 0.18 0.99 ± 0.79 
Interaction Genotype vs uCMS: 
F(1,36)= 4.40, p=0.05, η2partial=0.155 
Interaction Control vs uCMS: 
F(1,36)= 2.29, p=0.14, η2partial=0.09 
Interaction WT vs AP2γ+/-: 
F(1,36)= 3.19, p=0.08, η2partial= 0.12 
Average velocity 
WT AP2γ+/- 
t16= 0.96, p=0.35, Cohen’s d= 0.08 61.08 ± 2.06 65.6 ± 5.5 
EPM Time in closed arms 60.36 ± 5.33 70.49 ± 13.58 83.63 ± 6.85 78.39 ± 8.19 
Interaction Genotype vs uCMS: 
F(1,28)= 1.09, p=0.31, η2partial= 0.042 
Interaction Control vs uCMS: 
F(1,28)= 4.48, p=0.04, η2partial= 0.004 
Interaction WT vs AP2γ+/-: 
F(1,28)= 0.11, p=0.74, η2partial= 0.001 
FST Time of immobility 11.60 ± 1.62 14.30 ± 1.25 21.02 ± 2.24 18.38 ± 2.91 
Interaction Genotype vs uCMS: 
F(1,33)= 1.29, p=0.26, η2partial= 0.04 
Interaction Control vs uCMS: 
F(1,33)= 8.28, p=0.007, η2partial= 0.20 
Interaction WT vs AP2γ+/-: 
F(1,33)= 0.00009, p=, η2partial= 0.000003 
TST Time of immobility 56.90 ± 3.01 67.00 ± 3.77 69.85 ± 3.30 69.23 ± 5.05 
Interaction Genotype vs uCMS: 
F(1,33)= 1.59, p=0.22, η2partial= 0.20 
Interaction Control vs uCMS: 
F(1,33)= 3.19, p=0.04, η2partial= 0.28 
Interaction WT vs AP2γ+/-: 
F(1,33)= 1.24, p=0.27, η2partial= 0.152 
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18B, Table 21 and 22). Strikingly, in the constitutive animal model, upon uCMS exposure, WT animals 
developed significant impairment in this cognitive dimension whereas AP2γ+/- mice proved to be resilient 
to this deleterious effect of stress. In the conditional AP2γ KO model no differences were found between 
control and uCMS groups, suggesting that the chronic stress did not impact as much as in the 
constitutive KO animals, in this specific behavioral paradigm. Also through water maze paradigms, we 
performed the behavioral flexibility task, in which AP2γ+/- control animals displayed lower percentage of 
time spent in the new quadrant when compared to the WT control mice (Figure 17C, Table 21). 
Although barely failing to reach statistical difference, we could see the same tendency in the conditional 
KO animal model in which cAP2γ-/- presented lower percentage of time in the new quadrant when 
compared to the cAP2γ+/+ control group (Figure 18C, Table 22). Regarding the deleterious effect of 
stress in the reversal learning task, no differences were found between control and uCMS groups in the 
constitutive model. However, in the conditional model, chronic stress induced detrimental effects on the 
cAP2γ+/+ uCMS animals, and interestingly this result was not observed between the cAP2y-/- groups. 
After evaluating the cognitive behavioral dimension with the different water maze paradigms, we 
performed a cognitive test described to be sensitive to neurogenesis impairments, the CFC (Gu et al. 
2012). In this test, both animal models were submitted to a context probe, aimed to test hippocampal-
dependent memory, and a light-cued probe, designed to evaluate the integrity of extra-hippocampal 
memory circuits. In the context probe (context A), it was possible to observe in the constitutive AP2γ KO 
model that AP2γ+/- control group displayed a reduction in the percentage of time freezing when exposed 
to a familiar context (Figure 17D and Table 21). However, the same outcome was not observed in the 
cAP2γ-/- control, since no differences where found between this group and the cAP2γ+/+ control group 
(Figure 18D and Table 22). The detrimental effects of uCMS exposure were shown by the reduced time 
freezing of both constitutive WT uCMS and the conditional cAP2γ+/+ animals, when compared to the 
respective controls (Figure 17D and 18D, Table 21 and 22). Although not reaching statistical difference, 
it was also possible to see a clear tendency of cAP2γ-/-  uCMS mice to present a reduction in the 
percentage of time freezing when compared to the control group.  
In a second task, switching to a new environment (context B), promoted a decrease in the time 
freezing in all groups from both constitutive and conditional AP2γ KO animal models (Figure 17E and 
18E, Table 21 and 22). In the light probe, once again, all groups presented similar responses to the 
light cue, in both models (Figure 17F and 18F, Table 21 and 22). Overall, these CFC results show that 
AP2γ KO groups (AP2γ+/- and cAP2γ-/-) display specific deficits in contextual hippocampal-associated 
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memory which is exacerbated by the chronic stress exposure, while preserving associative non-
hippocampal dependent memory in both control and uCMS situations.   
 
Table 21. Statistical analysis of the behavioral tests used to evaluate the cognitive dimension of the 
constitutive AP2γ KO animal model.  
Data presented as mean ± SEM. In grey shading are the tests were it was observable differences between variables. 
Abbreviations: Trial (T), Day (D). 
 
 
 
 
 
 
 
 
Test 
Control uCMS Statistical test, significance, 
effect size WT AP2γ+/- WT AP2γ+/- 
 
 
Working 
memory 
 
T1 78.79 ± 4.29 95.25 ± 10.56 112.04 ± 4.66 89.00 ± 10.05 
F(1,17)=14.37, p<0.001, 
η2partial= 0.72 
T2 68.23 ± 9.64 83.31 ± 4.75 107.83 ± 2.86 88.40 ± 8.12 
T3 58.04 ± 7.58 78.75 ±10.73 108.4 ± 10.07 83.50 ± 8.05 
T4 60.71 ± 7.52 79.31 ± 13.63 97.83 ± 9.57 82.50 ± 1.71 
Spatial 
reference 
memory 
D1 107.2 ± 7.09 108.75 ± 6.88 105.79 ± 5.20 68.18 ± 11.28 
F(1,17)=12.37, p<0.001, 
η2partial= 0.69 
D2 54,00 ± 11.33 91.65 ± 9.06 117.13 ± 4.07 75.19 ± 17.20 
D3 40.83 ± 6.33 55.75 ± 9.40 100.6 ± 15.97 37.82 ± 14.56 
D4 28.37 ± 4.66 58.2 ± 9.48 109.0 ± 11.31 74.00 ± 23.23 
Behavioral flexibility 28.33 ± 4.08 14.71 ± 1.47 23.27 ± 2.03 27.32± 2.16 
Interaction Genotype vs uCMS: 
F(1,17)= 9.92, p=0.007, η2partial= 0.18 
Interaction Control vs uCMS: 
F(1,17)= 1.36, p=0.24, η2partial= 0.12 
Interaction WT vs AP2γ+/-: 
F(1,17)= 3.95, p=0.05, η2partial= 0.43 
CFC 
Context probe 
(context A) 73.56 ± 7.60 53.17 ± 9.25 57.38 ± 4.97 68.37 ± 2.41 
Interaction Genotype vs uCMS: 
F(1,19)= 15.32, p=0.001, η2partial= 0.45 
Interaction Control vs uCMS: 
F(1,19)= 0.02, p=0.90, η2partial= 0.12 
Interaction WT vs AP2γ+/-: 
F(1,19)= 1.37, p=0.26, η2partial= 0.20 
Context probe 
(context B) 
59.24 ± 6.59 36.51 ± 14.4 32.74 ± 6.94 47.86 ± 6.18 
Interaction Genotype vs uCMS: 
F(1,19)= 6.4, p=0.018, η2partial= 0.02 
Interaction Control vs uCMS: 
F(1,19)= 1.02, p=0.03, η2partial= 0.32 
Interaction WT vs AP2γ+/-: 
F(1,19)= 8.98, p=0.005, η2partial= 0.62 
Cue probe    
(context B) 
76.38 ± 6.24 61.52 ± 10.65 61.52 ± 7.56 90.26± 4.86 
Interaction Genotype vs uCMS: 
F(1,19)= 15.51, p=0.08, η2partial=0.46 
Interaction Control vs uCMS: 
F(1,19)= 1.57, p=0.23, η2partial= 0.08 
Interaction WT vs AP2γ+/-: 
F(1,19)= 1.57, p=0.23, η2partial= 0.08 
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Figure 17. Impact of the constitutive deletion of one allele of AP2γ in the cognitive behavioral dimension of 
depression. 
We started our cognitive dimension assessment by the water maze tests, in which we evaluated working memory (A), spatial 
reference (B) and reversal learning (C) tasks. In addition, animals were tested in a CFC paradigm, in the context probe (D and E) 
and in the cue probe (F). (Control: nWT= 8, nAP2γ+/-= 7 ; uCMS: nWT= 8, nAP2γ+/-=7; Data presented as mean ± SEM; *p<0.05, ***p<0.001; 
Data presented as mean ± SEM; p<0.05;**p<0.01. 
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Figure 18. Impact of the conditional deletion of AP2γ in the cognitive behavioral dimension of depression. 
We started our cognitive dimension assessment by the water maze tests, in which we evaluated working memory (A), spatial 
reference (B) and reversal learning (C) tasks. In addition, animals were tested in a CFC paradigm, in the context probe (D 
and E) and in the cue probe (F). Controls: n cAP2γ+/+= 12, ncAP2γ-/-=5; uCMS: n cAP2γ+/+=12, nAP2γ-/-=8; Data presented as mean ± SEM; 
*p<0.05. 
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Table 22. Statistical analysis of the behavioral tests used to evaluate the cognitive dimension of the 
conditional AP2γ KO animal model.  
Data presented as mean ± SEM. In grey shading are the tests were it was observable differences between variables. 
Abbreviations: Trial (T), Day (D). 
 
4.3. AP2γ modulatory mechanisms of adult hippocampal neurogenesis in 
depressive-like animals 
  
 4.3.1. AP2γ impact on the protein levels of different transcription factors involved 
in the adult hippocampal neurogenic process 
 To assess the functional impact of AP2γ deletion in the hippocampal glutamatergic neurogenic 
process, we quantified the protein expression of different transcripts involved in the transcriptional 
network responsible for the formation of new glutamatergic neurons in the adult hippocampal niche. To 
quantify these transcripts, we used western-blot (WB) analysis in brain tissue containing the total DG 
sample from both constitutive and conditional AP2γ KO animal models. 
Test 
Control uCMS Statistical test, significance, 
effect size cAP2γ+/+ cAP2γ-/- cAP2γ+/+ cAP2γ-/- 
WMT 
Working 
memory 
T1 85.04 ± 5.03 78.31 ± 6.79 92.1 ± 8.02 86.94 ± 12.24 
F(1,30)=0.38, p=0.77, 
η2partial= 0.04 
T2 73.00 ± 5.25 90.44 ± 14.39 70.03 ± 3.94 88.40 ±6.01 
T3 70.72 ± 7.55 72.32 ± 5.19 65.3 ± 8.45 66.11 ± 7.42 
T4 64.32 ± 7.23 83.00 ± 15.41 71.4 ± 7.58 77.89 ± 7.38 
Spatial 
reference 
memory 
D1 96.19 ± 5.98 103.7 ± 24.74 102.3 ± 7.50 106.9 ± 6.97 
F(1,30)=2.98, p=0.08, 
η2partial= 0.263 
D2 57.17 ± 6.08 80.63 ± 23.52 77.28 ± 10.66 66.6 ± 15.34 
D3 51.60 ± 7.39 89.50 ± 23.45 69.97 ± 10.76 71.85 ± 10.77 
D4 55.65 ± 5.82 84.44 ± 19.04 76.41 ± 7.74 55.75 ± 11.94 
Behavioral flexibility 29.71 ± 2.24 21.20 ± 2.15 20.12 ± 2.75 19.58 ± 1.68 
Interaction Genotype vs uCMS: 
F(1,30)= 9.92, p=0.007, η2partial= 0.08 
Interaction Control vs uCMS: 
F(1,30)= 6.96, p=0.02, η2partial= 0.15 
Interaction WT vs AP2γ+/-: 
F(1,30)= 2.97, p=0.10, η2partial= 0.11 
CFC 
Context probe 
(context A) 80.52 ± 3.2 76.68 ± 3.3 60.39 ± 2.7 54.24 ± 3.2  
Interaction Genotype vs uCMS: 
F(1,30)= 0.05, p=0.82, η2partial= 0.002 
Interaction Control vs uCMS: 
F(1,30)= 17.8, p=0.014, η2partial= 0.38 
Interaction WT vs AP2γ+/-: 
F(1,30)= 0.98, p=0.33, η2partial= 0.03 
Context probe 
(context B) 
41.48 ± 4.44 49.86 ± 7.64 37.81 ± 6.03 53.31 ± 9.18 
Interaction Genotype vs uCMS: 
F(1,30)= 0.33, p=0.57, η2partial= 0.01 
Interaction Control vs uCMS: 
F(1,30)= 0.0001, p=0.99, η2partial= 0.0001 
Interaction WT vs AP2γ+/-: 
F(1,30)= 3.75, p=0.08, η2partial= 0.11 
Cue probe  
(context B) 
86.78 ± 5.35 87.76 ± 9.27 85.92 ± 5.28 78.75 ± 4.29 
Interaction Genotype vs uCMS: 
F(1,30)= 0.93, p=0.341, η2partial= 0.02 
Interaction Control vs uCMS: 
F(1,30)= 1.37, p=0.25, η2partial= 0.04 
Interaction WT vs AP2γ+/-: 
F(1,30)= 0.54, p=0.47, η2partial= 0.02 
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 We started by quantifying the protein levels in the DG of constitutive AP2γ KO mice (Figure 19, 
Table 23) in which we confirmed a significant reduction of AP2γ protein levels in both AP2γ+/- control 
and after uCMS exposure when compared to the WT control and uCMS WT groups, respectively. 
Regarding the quantification of protein levels of upstream regulators of AP2γ also involved in 
glutamatergic neurogenesis, such as Sox2 and Pax6, no differences were observed between WT and 
AP2γ+/- control groups. However, after the noxious chronic stress stimulus we found a bolstering of Sox2 
in both WT (which barely fails statistical difference) and AP2γ+/- uCMS groups. Interestingly, we observed 
that the constitutive KO group has an increase of these transcript. In the Pax6 upstream regulator of 
AP2γ, we observed a similar protein expression pattern, finding once again a bolstering of expression 
after uCMS exposure in the AP2γ+/- group, but no differences were seen between WT control and uCMS 
groups. Moreover, a significant difference among the uCMS groups was observed, with AP2γ+/- mice 
exposed to uCMS showing an increased expression of Pax6 when compared to the WT uCMS group. 
When we analyzed the expression of the downstream target of AP2γ, Tbr2 (expressed in intermediate 
progenitor cells of the adult hippocampus), the AP2γ+/- control group showed a lower expression of this 
transcript when compared to the control WT group, although not reaching statistical significance. After 
uCMS exposure, no differences were found among the WT groups. However, Tbr2 showed increased 
expression in the DG of AP2γ+/- mice exposed to uCMS in comparison to the control AP2γ+/- group. 
 After quantifying the protein expression of transcription factors involved in adult glutamatergic 
neurogenesis of the hippocampal DG in the constitutive AP2γ KO mice, we proceeded with analysis in 
the DG of conditional KO mice (Figure 20, Table 24). Although, in this part of the results, the WB 
analysis of this model is still not completed, since the uCMS groups only include 1-2 animals per group, 
we were already able to observe the impact of AP2γ in the protein levels of several transcription factors 
involved in adult glutamatergic neurogenesis. We were able to confirm a significant reduction of AP2γ 
protein levels in the hippocampal DG of cAP2γ-/- control mice. However, no differences were observed 
between the control and uCMS exposed animals, nor among the uCMS groups. Regarding upstream 
regulators of AP2γ, we measured the protein level of Pax6, which showed a significant decreased 
expression in the cAP2γ-/- group when compared to its control group. Moreover, no alterations were 
observed between control and uCMS groups in the quantification of Pax6 protein levels. In the DCX 
measurements, similarly to the Pax6 results, we observed a decreased expression in the cAP2γ-/- mice 
when compared to its control group, but also a bolstering of its expression in the uCMS cAP2γ-/- mice 
when compared to the control cAP2γ-/- group. We further performed protein quantification of Tbr2 in the 
hippocampal DG, revealing a significant decrease of its expression in the control cAP2γ-/- group when 
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compared to the control cAP2γ+/+ mice. Furthermore, uCMS exposure induced a reduction of Tbr2 
expression in the cAP2γ+/+ mice, when compared to the respective control group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AP2γ impact on the protein levels of different transcripts involved in adult 
glutamatergic neurogenesis in the depressed-like constitutive KO animal model 
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Figure 19. Western blot analysis of Sox2, AP2γ Pax6 and Tbr2 in adult hippocampal dentate gyrus of the 
constitutive AP2γ KO animals. 
Representative blots for each genotype and condition (A); Protein expression levels with optical density (O.D.) normalized to 
actin, for each protein assessed (B). (Control: nWT= 5, nAP2γ+/-= 5; uCMS: nWT= 3, nAP2γ+/-= 3; Data presented as mean ± SEM; 
*p<0.05; ***p<0.001; #p=0.06). Abbreviations: Kilodalton (kDa). 
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Table 23. Statistical analysis of the western blots performed in the hippocampal dentate gyrus of AP2γ 
constitutive KO animals. 
Data presented as mean ± SEM. In grey shading are the groups between each it was observable statistical difference.  
 
 
 
 
 
 
Control uCMS Statistical test, significance, 
effect size WT AP2γ+/- WT AP2γ+/- 
Sox 2 Total DG 1.00 ± 0.24  1.41 ± 0.39  2.35 ± 0.83 7.67 ± 0.89  
Interaction Genotype vs uCMS: 
F(1,19)= 14.47, p=0.001, η2partial= 0.45 
Interaction Control vs uCMS: 
F(1,19)= 57.39, p=0.001, η2partial= 0.70 
Interaction WT vs AP2γ+/-: 
F(1,19)= 10.63, p=0.001, η2partial= 0.53 
Pax6 Total DG 1.00 ± 0.13 0.71 ± 0.14  0.67 ± 0.15 1.62 ± 0.31 
Interaction Genotype vs uCMS: 
F(1,20)= 9.81, p=0.005, η2partial= 0.33 
Interaction Control vs uCMS: 
F(1,20)= 2.15, p=0.16, η2partial= 0.10 
Interaction WT vs AP2γ+/-: 
F(1,20)= 2.78, p=0.11, η2partial= 0.12 
AP2γ Total DG 1.22 ± 0.16 0.66 ± 0.03  1.54 ± 0.24 0.67 ± 0.09 
Interaction Genotype vs uCMS: 
F(1,14)= 0.89, p=0.36, η2partial= 0.06 
Interaction Control vs uCMS: 
F(1,14)= 0.97, p=0.34, η2partial= 0.07 
Interaction WT vs AP2γ+/-: 
F(1,14)= 17.69, p=0.001, η2partial= 0.56 
Tbr2 Total DG 1.00 ± 0.17 0.46 ± 0.10  1.09 ± 0.25 1.98 ± 0.53 
Interaction Genotype vs uCMS: 
F(1,26)= 5.88, p=0.02, η2partial= 0.19 
Interaction Control vs uCMS: 
F(1,26)= 7.42, p=0.01, η2partial= 0.22 
Interaction WT vs AP2γ+/-: 
F(1,26)= 0.36, p=0.55, η2partial= 0.01 
AP2γ impact on the protein levels of different transcripts involved in the adult 
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 Figure 20. Western blot analysis of 
AP2γ, Pax6, DCX and Tbr2 in adult 
hippocampal dentate gyrus of the 
conditional AP2γ KO animals. 
Representative blots for each genotype 
and condition (A); Protein expression 
levels with optical density (O.D.) 
normalized to actin, for each protein 
assessed (B). (Control: ncAP2γ+/+= 5, ncAP2γ -/-= 
5; uCMS: ncAP2γ+/+= 1-2, ncAP2γ -/-= 2; Data 
presented as mean ± SEM; *p<0.05; 
**<0.01; ***p<0.001) 
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Table 24. Statistical analysis of the western blots performed in the hippocampal dentate gyrus of AP2γ 
conditional KO animals. 
Data presented as mean ± SEM. In grey shading are the groups between each it was observable statistical difference. 
 
4.3.2. AP2γ transcription factor impact on epigenetic regulators of adult 
hippocampal glutamatergic neurogenesis  
 In this thesis we also started to assess epigenetic mechanisms that have been proposed to play 
crucial roles in adult glutamatergic neurogenesis, namely DNA methylation and demethylation 
mechanisms. Although until this point we do not have highly conclusive results, a broad analysis was 
possible to obtain.  
 We started an epigenetic characterization through a sensitive but general way of testing, by 
targeting specific known mediators of DNA methylation and demethylation in the AP2γ constitutive KO 
mice. DNA methylation was first evaluated through the quantification of DNMT3a and DNMT3b 
(enzymes involved in the chemical covalent addition of a methyl group to the fifth carbon in the cytosine 
pyrimidine ring) mRNA expression by quantitative real-time (qRT)-PCR in the dorsal and ventral DG 
samples. No differences were found in the expression of these two enzymes, both between genotypes 
and among control and uCMS conditions in the dorsal and ventral DG (Figure 21A-D; Table 26). 
However, when we assessed the DNA demethylation process through the quantification of the ten 
eleven translocation (TET) family of enzymes, which are largely responsible for the active DNA 
demethylation process, we could observe in the dorsal DG that all three enzymes (TET 1, TET 2 and 
 
Control uCMS Statistical test, significance, 
effect size cAP2γ+/+ cAP2γ-/- cAP2γ+/+ cAP2γ-/- 
DCX Total DG 1.00 ± 0.05 1.41 ± 0.05  0.84 ± 0.00 7.67 ± 0.16 
Interaction Genotype vs uCMS: 
F(1,15)= 20.54, p=0.0004, η2partial= 0.58 
Interaction Control vs uCMS: 
F(1,15)= 9.01, p=0.009, η2partial= 0.38 
Interaction WT vs AP2γ+/-: 
F(1,15)= 5.01, p=0.05, η2partial= 0.53 
Pax6 Total DG 0.99 ± 0.04 0.52 ± 0.10  0.70 ± 0.07 0.85 ± 0.11 
Interaction Genotype vs uCMS: 
F(1,28)= 6.26, p=0.02, η2partial= 0.18 
Interaction Control vs uCMS: 
F(1,28)= 0.03, p=0.86, η2partial= 0.001 
Interaction WT vs AP2γ+/-: 
F(1,28)= 1.72, p=0.20, η2partial= 0.06 
AP2γ Total DG 1.01 ± 0.02 0.47 ± 0.16  0.49 ± 0.09 0.37 ± 0.01 
Interaction Genotype vs uCMS: 
F(1,18)= 4.45, p=0.05, η2partial= 0.20 
Interaction Control vs uCMS: 
F(1,18)= 10.17, p=0.06, η2partial= 0.36 
Interaction WT vs AP2γ+/-: 
F(1,18)= 11.3, p=0.003, η2partial= 0.39 
Tbr2 Total DG 1.00 ± 0.05 0.56 ± 0.15  0.35 ± 0.10 0.36 ± 0.05 
Interaction Genotype vs uCMS: 
F(1,24)= 2.86, p=0.10, η2partial= 0.10 
Interaction Control vs uCMS: 
F(1,24)= 9.27, p=0.006, η2partial= 0.28 
Interaction WT vs AP2γ+/-: 
F(1,24)= 2.70, p=0.11, η2partial= 0.10 
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TET 3) showed a significant reduced expression in the AP2γ+/- group after exposure to uCMS when 
compared to the control AP2γ+/- mice (Figure 22A, C and E; Table 26). Moreover, we did observe the 
same tendency of TET 1 gene expression in the ventral DG (Figure 22B; Table 26). No differences were 
found between the WT groups in both dorsal and ventral DG, and although we could observe a tendency 
for the AP2γ+/- group to show higher expression of all three enzymes in control conditions, no statistical 
differences were found among genotypes. 
 
 
 
 
 
 
 
 
 
Epigenetic methylation in the hippocampal dentate gyrus of AP2γ constitutive KO animals 
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Figure 21. Epigenetic modulators involved in DNA methylation in the hippocampal DG of AP2γ constitutive 
KO depressed-like animals. 
DNMT3a (A and B) and DNMT3b (C and D) gene expression was quantified through qRT-PCR. Data is presented with fold 
change values in the dorsal and ventral DG of AP2γ constitutive KO depressed-like animals. (Control: nWT= 3, nAP2γ+/-= 3; uCMS: 
nWT= 3, nAP2γ+/-=3; Data presented as mean ± SEM. 
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Table 25. Statistical analysis of DNMTs gene expression quantification in the dorsal and ventral DG of the 
constitutive AP2γ KO animal model. 
Data presented as mean ± SEM. 
 
Table 26. Statistical analysis of the TET genes expression quantification in the dorsal and ventral DG of the 
constitutive AP2γ KO animal model. 
Data presented as mean ± SEM. 
 
 
Control uCMS Statistical test, 
significance, effect size WT AP2γ+/- WT AP2γ+/- 
TET 1 
Dorsal 
DG 
0.001 ± 0.0002 0.002 ± 0.0001 0.001 ± 0.0001 0.008 ± 0.0003 
Interaction Genotype vs uCMS: 
F(1,5)= 11.35, p=0.02, η2partial= 0.70 
Interaction Control vs uCMS: 
F(1,5)= 9.86, p=0.02, η2partial= 0.66 
Interaction WT vs AP2γ+/-: 
F(1,5)= 0.09, p=0.77, η2partial= 0.02 
Ventral 
DG 
0.001 ± 0.0003 0.002 ± 0.002 0.001 ± 0.0002 0.001 ± 0.0001 
Interaction Genotype vs uCMS: 
F(1,5)= 7.83, p=0.04 η2partial=0.61  
Interaction Control vs uCMS: 
F(1,5)= 6.16, p=0.06, η2partial=0.55  
Interaction WT vs AP2γ+/-: 
F(1,5)= 1.74, p=0.24, η2partial=0.26  
TET 2 
Dorsal 
DG 
0.39 ± 1.66 0.29 ± 0.01 0.55 ± 0.09 0.23 ± 0.06 
Interaction Genotype vs uCMS: 
F(1,4)= 6.08, p=0.07, η2partial=0.60  
Interaction Control vs uCMS: 
F(1,4)= 21.52, p=0.009, η2partial=0.84  
Interaction WT vs AP2γ+/-: 
F(1,4)= 1.34, p=0.32, η2partial=0.25 
Ventral 
DG 
0.37 ± 1.53 0.48 ± 0.06 0.39 ± 0.07 0.45 ± 0.05 
Interaction Genotype vs uCMS: 
F(1,4)= 0.19, p=0.68, η2partial=0.05 
Interaction Control vs uCMS: 
F(1,4)= 0.003, p=0.96, η2partial= 0.001 
Interaction WT vs AP2γ+/-: 
F(1,4)= 3.19, p=0.15, η2partial= 0.44 
 
Control uCMS Statistical test, significance, 
effect size WT AP2γ+/- WT AP2γ+/- 
DNMT3a 
Dorsal 
DG 
0.013 ± 0.003 0.11 ± 0.003 0.11 ± 0.002 0.007 ± 0.0003 
Interaction Genotype vs uCMS: 
F(1,6)= 0.16, p=0.7, η2partial= 0.03 
Interaction Control vs uCMS: 
F(1,6)= 2.90, p=0.14, η2partial= 0.33 
Interaction WT vs AP2γ+/-: 
F(1,6)= 1.93, p=0.21, η2partial= 0.24 
Ventral 
DG 
0.012 ± 0.003 0.14 ± 0.002 0.011 ± 0.001 0.01 ± 0.0004 
Interaction Genotype vs uCMS: 
F(1,7)= 0.32, p=0.59, η2partial=0.04  
Interaction Control vs uCMS: 
F(1,7)= 1.39, p=0.28, η2partial=0.17  
Interaction WT vs AP2γ+/-: 
F(1,7)= 0.52, p=0.06, η2partial=0.07  
DNMT3b 
Dorsal 
DG 
0.057 ±  0.04 0.003 ± 0.02 0.03 ± 0.006 0.014 ± 0.009 
Interaction Genotype vs uCMS: 
F(1,7)= 2.14, p=0.19, η2partial=0.23  
Interaction Control vs uCMS: 
F(1,7)= 0.09, p=0.77, η2partial=0.01  
Interaction WT vs AP2γ+/-: 
F(1,7)= 0.54, p=0.49, η2partial=0.71 
Ventral 
DG 
0.049 ± 0.04 0.026 ± 0.01 0.009 ± 0.001 0.008 ± 0.002 
Interaction Genotype vs uCMS: 
F(1,7)= 0.22, p=0.65, η2partial=0.03 
Interaction Control vs uCMS: 
F(1,7)= 1.73, p=0.23, η2partial= 0.19 
Interaction WT vs AP2γ+/-: 
F(1,7)= 0.31, p=0.59, η2partial= 0.04 
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TET 3 
Dorsal 
DG 
0.0004 ± 0.008 0.0007 ± 0.0002 0.0003± 0.0001 0.0003 ± 0.0001 
Interaction Genotype vs uCMS: 
F(1,4)= 6.00, p=0.07, η2partial=0.60 
Interaction Control vs uCMS: 
F(1,4)= 24.0, p=0.008, η2partial= 0.86 
Interaction WT vs AP2γ+/-: 
F(1,4)= 6.00, p=0.07, η2partial= 0.60 
Ventral 
DG 
0.0004 ± 0.002 0.0005 ± 0.0002 0.0003 ±0.00001 0.0002 ± 0.0001 
Interaction Genotype vs uCMS: 
F(1,7)= 0.98, p=0.36, η2partial=0.14 
Interaction Control vs uCMS: 
F(1,7)= 2.1, p=0.20, η2partial= 0.26 
Interaction WT vs AP2γ+/-: 
F(1,7)= 0.15, p=0.72, η2partial= 0.02 
 
 
Epigenetic demethylation in the hippocampal dentate gyrus of AP2γ constitutive KO animals 
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Figure 22. Epigenetic modulators involved in DNA demethylation in the hippocampal DG of AP2γ constitutive KO 
depressed-like animals. 
TET1 (A and B), TET2 (C and D) and TET3 (E and F) gene expression was quantified through qRT-PCR. Data is presented with fold 
change values in the dorsal and ventral DG of AP2γ constitutive KO depressed-like animals. (Control: nWT= 2, nAP2γ+/-= 2; uCMS: nWT= 2, 
nAP2γ+/-=2 Data presented as mean ± SEM; *p<0.05). 
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5. DISCUSSION 
 
5.1. Role of the transcription factor AP2γ during postnatal development 
 
 The AP2γ gene belongs to the AP2 family of transcription factors, which in mammals are 
largely associated with embryonic development. These transcription factors play crucial roles in various 
systems and biological processes, such as cell proliferation, cell adhesion, developmental 
morphogenesis, tumor progression and cell fate determination, through the regulation of a large 
number of target genes with different biological functions (Batsche et al. 1998; Ebert et al. 1998; 
Maconochie et al. 1999; Kuckenberg et al. 2012; Cyr et al. 2015). In mice, AP2γ is expressed during 
developmental stages, both in the central and peripheral nervous system (Pinto et al. 2009), as well as 
in the adult mouse forebrain (Pinto et al. 2009) and also in the SGZ of the hippocampal DG and the 
SEZ of the lateral ventricles (Mateus-Pinheiro et al. 2016). Perceiving the relevancy of this specific 
transcription factor in the primordial embryonic developmental stages makes it easy to understand why 
mice with homozygous deletion of AP2γ since embryonic development are not viable.   
Therefore, knowing the importance of this transcription factor in embryonic development and in 
the adult neurogenesis process, combined with previous results from the group suggesting impairments 
in hippocampal glutamatergic neurogenesis (Mateus-Pinheiro et al. 2016), we wanted to understand if 
during post-natal neurodevelopment there were already deficits in the heterozygous AP2γ constitutive 
KO mice. To do so, we used the developmental milestones protocol, a simple procedure that is easy to 
measure, requires little equipment and includes a vast range of assays as indicators of both 
neurological, strength and motor development (Hill et al. 2008). 
In general, all litters that have been tested for the developmental milestones protocol presented 
a normal development and no particular traits were noticed in body weight and anogenital distance, 
which are mainly physical and somatic parameters. Also, any relevant alterations were observed in 
motor development as assessed by the open field and walking tests, or in the sensorial parameters, as 
evaluated by the grasping, auditory startle, rooting and ear twitch tests. The only somatic and 
neurobiological differences found between groups were on the eye opening day, in the negative geotaxis 
and in the wire suspension tests, as seen by the delay and anticipation in the timing (measured as 
days) to acquire a mature response by the AP2γ+/- group. These AP2γ+/- animals showed a delay for 1 
day in the negative geotaxis test, and 1, 2 days of anticipation for the eye opening day and the wire 
suspension mature response, respectively. Regarding the somatic anticipation in the AP2γ+/- group we 
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do not have a clear cause for this occurrence, and we believe that probably there is no biological 
meaning in this difference between the two groups. One aspect that we have to consider in this 
protocol, and that might be causing this small difference between the groups, is the different time of 
birth of the litters. Our strategy to control animal’s birth was to check twice a day (in the morning, and 
at the end of the afternoon) if there were already pups in the animals’ cage. These discrepancies in 
time between litters may lead in some milestones tests to discrete differences, and we do believe that 
this is the case for the eye opening test. Also corroborating the normality of the eye opening day is the 
fact that both groups opened both of their eyes within the normal range of maturity in this somatic test, 
which is between PND7-17 (Heyser 2001). 
If we would only take in consideration the two obtained neurobiological differences in the 
negative geotaxis and wire suspension tests, it would be possible to indicate some sort of deficit 
associated with strength or muscular rigidity. However, in other developmental milestones protocol 
parameters, which also evaluated strength domains (like the surface righting, cliff aversion and air 
righting tests) we did not observe any kind of impairment between groups, indicating no deficits in this 
evaluated domain. Moreover, both results are within the normal range for rodents to acquire the mature 
response: defined for the negative geotaxis test to be between PND6-PND15 and for the wire 
suspension test between PND10-PND16 (Heyser 2001). In the future, it would be interesting to confirm 
these results through a more sensitive molecular approach. One way to do so could be through high-
performance liquid chromatography (HPLC) in which we could quantify different neurotransmitters 
involved in strength, such as dopamine, which has been associated with muscular rigidity when present 
in lower percentages (Hemsley and Crocker 2001; Konieczny et al. 2009). 
 
5.2. The role of AP2γ in juvenile mice 
 
 5.2.1. Impact of AP2γ on behavioral performance of juvenile mice 
In previous studies from the group, we performed a multidimensional behavioral 
characterization of the AP2γ+/- adult mice in basal conditions. However, it was not analyzed if the 
modulatory effects of the transcription factor AP2γ on behavior, are indeed specifically observed at adult 
stages, or if during the developmental and maturity stages there is already an effect of the constitutive 
deletion of one allele of the AP2γ gene. Therefore, to start dissecting the precise role of AP2γ 
throughout postnatal development, in this thesis we used a set of established behavioral tests to 
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analyze WT and AP2γ+/- animals and study the modulatory effect of AP2γ deletion already in juvenile 
stages.  
There is some information available regarding the proper age to test juvenile mice, but one of 
the most accepted and published ages is between 3 to 8 weeks. Taking this in consideration, the 
behavioral profile of the animals was assessed between PND25 to PND31, and as such we had to 
adapt in some situations the behavioral test to overcome limitations of the young age of the animals. 
We started the juvenile behavior characterization by evaluating if AP2γ deletion has an impact on the 
anxious-like behavior of the juvenile mice through the OF test. Although it is not described as a classical 
test for anxiety, the OF test can also be used as an indicator of anxious-like behavioral states of rodents, 
by evaluating the ratio of time spent and distanced traveled in the center versus the periphery of the 
arena (Prut and Belzung 2003). After a first trial with a small group of animals, we noticed that the 
habitual 5 min per trial in the OF arena was not sufficient to understand any kind of phenotype, as the 
majority of the animals did not perform the test, spending almost the total time in a resting state. We 
decided to adapt the time session for 20 min per trial, to allow the young animals to acclimatize to the 
light stimulus of the arena. Under these conditions we observed that the AP2γ+/- mice traveled lower 
distances and spent less time in the center of the arena, suggesting higher anxiety levels when 
compared to the WT group. Interestingly, the same pattern was found in the adult AP2γ+/- group at basal 
conditions, suggesting that this susceptibility to an anxious-like behavior already occurs during juvenile 
development.  
Then we assessed if in basal conditions there are any signs of susceptibility to behavioral 
despair, through the TST. We did not find any difference between AP2γ+/- and WT juvenile mice in the 
percentage of time that the mice stay immobile during the test, suggesting the absence of depressive-
like symptoms in AP2γ+/- juvenile mice. Also in the splash test we did not find differences between 
groups in the time that the animals spent grooming after applying a sucrose solution to their coat, 
further indicating that AP2γ+/- juvenile mice do not present core alterations in motivational self-care. 
Together, both results indicate that AP2γ deletion does not cause any predisposition towards a 
depressive-like behavior in juvenile ages. The same pattern was found during adulthood in the FST, thus 
corroborating this hypothesis. 
One of our main goals with the juvenile behavior assessment was also to understand if  AP2γ 
could have a modulatory role in the cognitive performance of juvenile mice, since in previous studies we 
obtained results suggesting its importance in modulating cognition of adult mice. Although Carr and 
colleagues already assessed cognition in juvenile mice (from PDN16 to PND22) (Carr et al. 2016), we 
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tried to assess it in our juvenile animals through the same novel object recognition (NOR) protocol but 
the animals did not perform this behavioral test. We further tried to explore this dimension through the 
social interaction and Y-maze tests, and once again animals did not perform these behavioral 
paradigms. Thus, until this moment we were not able to evaluate how AP2γ transcription factor is 
impacting on the cognitive performance of juvenile mice. 
  
5.2.2. AP2γ modulation of hippocampal proliferation and neurogenesis in juvenile 
mice 
In previous studies from the group hippocampal dentate gyrus (DG) cell proliferation and 
glutamatergic neurogenesis in the brain of AP2γ+/- adult mice was already characterized. However, it 
was not analyzed if these effects in the adult mice promoted by deletion of AP2γ are indeed specifically 
observed at adult stages, or if during the developmental and maturity stages there is already an effect of 
the constitutive deletion of one allele of AP2γ in hippocampal neurogenesis. To comprehend if the 
reduced expression of AP2γ could have already an impact on hippocampal glutamatergic neurogenesis 
during development and maturity stages, we injected juvenile animals with BrdU and sacrificed them 
24h later (at PND31), allowing us, through immunostaining, to assess the proliferation of progenitor 
cells and newborn neurons (neuroblasts expressing doublecortin – DCX). Analysis of total cell 
proliferation in the DG of WT and AP2γ+/- animals revealed no significant differences between groups, 
although the proliferation values of AP2γ+/- animals were slightly reduced. In addition, we analyzed the 
number of newborn neuroblasts with double staining for BrdU and DCX, revealing a significant 
difference between WT and AP2γ+/- animals. In AP2γ+/- mice, a decreased number of neuroblasts was 
observed as shown by the reduced number of double-positive BrdU/DCX cells, when compared to the 
WT control group. 
These deficits in newborn neurons, observed in juvenile animals with constitutive deletion of 
one allele of AP2γ, confirm the modulatory involvement of AP2γ in the modulation of post-natal 
glutamatergic neurogenesis in the healthy brain, already during development and maturity of these 
animals. Impairments in the generation of new hippocampal neurons have been largely associated with 
a more anxious phenotype (Revest et al. 2009; Hill et al. 2015). In our juvenile behavioral results we 
could observe through the OF test a higher anxiety level in the AP2γ+/- animals, since this KO mice 
traveled lower distances and spent less time in the center of the arena. Through these results we can 
suggest that the modulation exerted by the reduce expression of AP2γ transcription factor in the 
constitutive KO mice, is impairing the glutamatergic neurogenic process and causing a striking increase 
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in anxiety-related behavior. In the future, it would be interesting to quantify the expression of different 
AP2γ targets, to understand if at this point of development, it is already noticeable an altered presence 
of different transcripts involved in the post-natal glutamatergic process, such as Sox2, Pax6 and Tbr2. 
Also associated with impaired generation of new glutamatergic neurons in the hippocampus are the 
cognitive deficits (Shen et al. 2006; Deng et al. 2009; Jessberger et al. 2009). Thus, it becomes 
relevant to find suitable behavioral cognitive tests to assess if indeed this decreased neuronal 
generation leads to impaired cognitive performance of juvenile mice, as also seen by the deficits in the 
contextual-hippocampal associated memory and behavioral flexibility during adulthood (Mateus-Pinheiro 
2016). Although in the duration of this thesis we were not able to successfully assess the cognitive 
performance of juvenile mice, in later results we adapted the NOR protocol to the night time period, 
since it is the active phase of the animals. In a preliminary trial with WT animals we observed that 
animals are indeed more actively performing the test when compared to the diurnal results. As such, in 
the future we plan to assess the cognitive behavior of both WT and AP2γ+/- juvenile mice in the nocturnal 
period.  
The anxious and cognitive domains are largely associated with the post-natal glutamatergic 
neurogenic process, being the impairments in the emotional dimension more associated to deficits in 
the neurogenic process of the ventral DG, and the cognitive deficiencies more related to deficits in the 
glutamatergic neurogenesis occurring in dorsal DG (Kheirbek and Hen 2011). As such, in the future it 
would be interesting to discriminate the neurogenic alterations in these two areas of the DG, in order to 
better understand the behavioral phenotype, as previously performed in the adult mice (Mateus-Pinheiro 
et al. 2016). 
 
5.3. Functional impact of the transcription factor AP2γ in depression  
 
5.3.1. The uCMS protocol as a model of depression  
To validate the uCMS protocol implemented in this master thesis study two major measures 
were used to control its efficacy: the body weight gained throughout the six weeks of uCMS protocol and 
the levels of corticosterone in blood at the end of the chronic stress exposure. Through the body weight 
gain, we already were able to observe imbalances between control and animals exposed to chronic 
stress in both models. During uCMS protocol, the control animals were gaining and maintaining the 
gained weight whereas the mice exposed to stress from both genotypes and models were first loosing 
and maintaining the weight lost throughout the six weeks of the chronic stress protocol. These findings 
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alone already are good validators of the efficacy of the uCMS protocol as a model to induce depressive-
like features (Retana-Marquez et al. 2003; Bhatnagar et al. 2006). However, we wanted to perceive if 
these differences in body weight were really an indicator of a depressive-like state, or if it was a 
consequence of the food deprivation during some mild stressors. For that, we proceeded to a molecular 
analysis quantifying the levels of corticosterone in blood of the animals at the final week of the uCMS 
protocol. 
As previously described, the circadian distribution of corticosterone in control rodents is 
characterized by a basal quantity at day time (nadir) and a night time peak (zenith) (D'Agostino et al. 
1982). This circadian regulation of corticosterone secretion was found to be altered in animals exposed 
to stressful events, suggesting a disruption of the HPA axis (Ottenweller et al. 1994). In healthy 
conditions, the HPA axis is the major neuroendocrine system that controls organisms’ reactions. Upon 
acute stress stimulation, the axis releases corticotrophin-releasing hormone (CRH) from the 
paraventricular nucleus of the hypothalamus, which in turn acts on the pituitary gland inducing 
adrenocorticotropic (ACTH) release from the pituitary into the circulatory system. In the periphery, 
corticosteroids are then secreted from the adrenal gland. A negative feedback mediated by 
corticosteroids on the hypothalamus, pituitary and higher brain centers ensures the equilibrium of the 
system (Bhatnagar et al. 2006; Femenia et al. 2012).  
It is known that chronic stress exposure is accompanied by HPA axis hyperactivity, resulting in 
deregulated glucocorticoid secretion-pattern into the blood (Schoenfeld and Gould 2012). In our results, 
we observed that both constitutive and conditional KO control groups maintained a normal circadian 
rhythm of corticosterone secretion, since there is a significantly peak of corticosterone at the zenith 
time-point. The uCMS exposed animals showed a disruption of the HPA axis by presenting a 
significantly higher nadir levels of corticosterone than the control groups, and no circadian regulation, 
as there are no differences between nadir and zenith in both constitutive and conditional KO uCMS 
groups.  
Together, the imbalances in the weight gain and the disruption of the corticosterone circadian 
rhythm, validate the efficacy of the uCMS protocol in both animal models, a shoring in this way, that the 
animals presented core symptoms of depressive-like disorder. 
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5.3.2. Role of AP2γ in the modulation of behavioral domains affected by 
depression 
 The confirmation of the modulatory role of AP2γ on the adult hippocampal neurogenic process 
opens exciting perspectives regarding the importance of these gene in neuropathological contexts in 
which neurogenesis is impaired, such as depression. Having this in mind, we decided to study if AP2γ 
deletion also modulates adult hippocampal neurogenesis and behavior in depressive-like animals. For 
this, we exposed both AP2γ KO constitutive and conditional animal models to an uCMS protocol. 
The behavioral profile of the animals was assessed immediately after the six weeks of chronic 
stress exposure. The uCMS protocol successfully induced depressive-like behavior in the chronic 
stressed WT (WT and cAP2γ+/+) animals from both models, reflected in a substantial increase of 
immobility in the FST (for both models) and in the TST (for the conditional model). However, no 
differences were found between the KO (AP2γ+/- and cAP2γ-/-) and the WT (WT and cAP2γ+/+) groups, 
suggesting that the reduced expression of AP2γ did not affect the mood of mice. Interestingly, and 
considering that the hippocampal neurogenic process of these two different groups of AP2γ KO mice is 
partially compromised (Mateus-Pinheiro et al. 2016), this finding matches the results reported by Bessa 
et al (Bessa et al. 2009a), in which it was shown that stressed animals with and without suppressed 
neurogenesis spend higher periods of time immobile in the FST comparing to control animals, but that 
these two groups did not differ between them. Furthermore, anxiety-related behavior assessed by the 
OF and the EPM tests, was found to be affected by the uCMS protocol in both mice models analyzed, 
reflected in a substantial decreased distance traveled and time spent in the center of the arena in the 
OF test by the WT uCMS groups, and the increased time in enclosed arms of the EPM apparatus by the 
same referred animals. Notably, in these two behavioral tests, different trends regarding the control 
situations were observed, since in the OF test we could observe an anxious-like behavior in the AP2γ KO 
groups, which was not the case in the EPM test. However, we have to take in consideration that the 
different behavioral tests employed to assess the anxiety-related behavior have advantages and 
limitations such as all the paradigms used to assess animal’s behavior. Moreover, these different 
behavioral tests measure different fractions of an animal’s emotional profile, making it possible to 
obtain distinct phenotypes from both tests. To further dissect the role of AP2γ in anxiety-like behavior 
we may in the future perform additional behavioral tests, like the light-dark box test, which can also 
provide valuable insights regarding this behavioral dimension (Bourin and Hascoet 2003). 
The most interesting findings in the characterization of the behavioral profile of AP2γ KO adult 
mice are related to cognition. Indeed, the constitutive deletion of AP2γ exerted significant impacts on 
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mice cognitive performance in the working and spatial reference memory, and also in the reversal 
learning task. Exposure to uCMS induced highly significant deficits on working memory and reference 
memory of the constitutive WT mice, an effect that was completely absent in the AP2γ+/- stressed mice. 
This is an interesting observation that seemed to be associated to some compensatory mechanism in 
AP2γ+/- animals exposed to stress, that lead to the reinforcement of the hippocampal neuronal 
population, thus counteracting the deleterious effects of stress in this cognitive dimension. Interestingly, 
this proved to be case, as data from the protein levels of different transcripts involved in adult 
glutamatergic neurogenesis, namely Sox2, Pax6 and Tbr2 seem to be highly expressed in uCMS AP2γ+/- 
animals when compared to the WT stressed mice.  
Moreover, in the reversal learning task in the water maze test and in the context probe from the 
CFC test, AP2γ+/- mice already showed significant deficits in contextual hippocampal-associated memory 
and impaired hippocampal-to-PFC network in basal conditions, independently of stress exposure. 
Likewise, in the conditional AP2γ KO model a tendency was found in the reversal learning task in which 
cAP2γ-/- presented lower percentage of time in the new quadrant when compared to the cAP2γ+/+ control 
group. Regarding the deleterious effect of stress in the reversal learning task, in the conditional model, 
chronic stress induced detrimental effects on the cAP2γ+/+ uCMS animals, and interestingly this result 
was not observed between the cAP2γ-/- groups. However, no differences were found between control 
and uCMS groups in the constitutive model.  
Taking into consideration that this deficiency in AP2γ in the constitutive model is present since 
embryonic development, most likely it has affected cortical basal progenitors specification, accounting 
for deficits in neocortical development, as previously shown (Pinto et al. 2009). As the reversal learning 
task is closely related to PFC functions, deficits observed in the control AP2γ+/- are probably due to 
misspecification of cortical layers in this cortical region, that ultimately leads to defects on cognitive 
activities in which PFC is actively involved. Interestingly, in previous electrophysiological studies from 
the group, we showed that in basal conditions, the AP2γ deficiency in the adult brain of the conditional 
cAP2γ-/- mice led to a significant decrease of coherence between the ventral hippocampus and the PFC 
(Mateus-Pinheiro et al. 2016), indicating a decrease in the ability of these two region to functionally 
interact, previously shown to be critically related with behavior outputs dependent on cortico-limbic 
networks (Fell and Axmacher 2011; Gordon 2011). Moreover, the integrity of the ventral hippocampus-
to-PFC link has been recently described to be important to the antidepressant action of drugs, such as 
ketamine (Carreno et al. 2016), raising the possibility that AP2γ may play an important role in the 
preservation of this neuronal circuit (Mateus-Pinheiro et al. 2016). In the future, it would be interesting 
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to explore this electrophysiological measurements in the context of depression, in order to better 
perceive how AP2γ influences interregional communication in the pathogenesis of psychiatric disorders.  
 
5.3.3. The modulatory action of AP2γ in the hippocampal neurogenic niche 
 The behavioral profile of the constitutive and conditional AP2γ KO groups was altered in the 
assessed cognitive domains. As previously discussed, the evident decline in the performance of AP2γ 
KO animals in the reversal learning tasks is likely a consequence of defects on cortical development, 
and also impairments in neuronal circuits that create deficits in interregional communication. At this 
point, further studies are needed to fully assess if this is indeed the cause underlying the observed 
behavioral phenotypes. However, driven by the observed resilience to the deleterious effects of uCMS 
exposure on the reference memory – an hippocampal-dependent function – we hypothesized whether 
such phenotype could be also related to alterations in the hippocampal neurogenic niche. To prove so, 
we started to quantify the impact of AP2γ on the protein levels of different transcripts involved in the 
adult glutamatergic neurogenic process in both depressed constitutive and conditional animal models.  
Although we are aware, that further studies are needed to fully comprehend the effect of AP2γ 
in the hippocampal dentate gyrus and its repercussion on the altered cognitive function, we started this 
hippocampal neurogenesis characterization through western blots quantification. As it was possible to 
observe, both models showed a significant reduction on AP2γ protein levels in the hippocampal DG, 
wherein the conditional model was highly impacted by the tamoxifen-inducible deletion of AP2γ. 
Moreover, AP2γ reduction in the constitutive animal model triggered a reduction of Tbr2 protein levels, 
but had no impact on its upstream regulators such as Sox2 and Pax6. However, in the conditional AP2γ 
model, all the transcripts measured seem to be highly impacted by the deficits in AP2γ since cAP2γ-/- 
control mice have reduced expression of Pax6, DCX and also Tbr2.  
Regarding the uCMS conditions we had an interesting finding in the AP2γ constitutive KO model 
that lead us to hypothesize that compensatory mechanisms during developmental stages may happen. 
After uCMS exposure the AP2γ+/- animals showed a high bolstering of Sox2, Pax6 and Tbr2, which, like 
previously reported, are highly involved in the modulation of adult hippocampal glutamatergic 
neurogenesis. We may hypothesize that by having a developmental defect in neuronal progenitor cells 
since embryonic development, this neuropathological target is already affected, thereby contributing to 
a minor extent to the pathological repercussions of chronic stress exposure. This phenomenon, can be 
attributable to compensatory mechanisms that emerged by the constitutive deletion of one allele of the 
AP2γ gene since embryonic development, similarly to what happens with several cell proliferation 
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regulatory molecules and their binding partners cyclins (Satyanarayana and Kaldis 2009). Another 
possibility is that functionally redundant members of the AP2 transcription factors family may also 
interplay the lack of AP2γ, reinforcing hippocampal cell proliferation both in basal and in 
neuropathological contexts. Interestingly, and although in the conditional AP2γ model the WB 
quantifications are not yet fully concluded in uCMS conditions, the same pattern was not observed, 
further supporting the contribution of putative compensatory mechanism that emerged since early 
development in the constitutive KO model.  
To better understand the modulatory impact of AP2γ in hippocampal neurogenesis and its 
repercussions on the cognitive dimension, further complementary studies are required in both KO 
models, such as DG immunostainings for proliferative markers, analysis of the dendritic morphology of 
DG granular neurons, spine densities and morphology. Moreover, complementing these results with 
electrophysiological characterization of the hippocampus-to-PFC network in uCMS conditions would 
bring some insights if the interregional communication dysfunction emerges as a consequence of 
glutamatergic network malfunction triggered by the lack of AP2γ regulation in the adult neurogenic 
niche.  
  
5.4. AP2γ impacts on epigenetic regulators of adult hippocampal glutamatergic 
neurogenesis – A preliminary perspective  
  
Epigenetic mechanisms have been proposed to play pivotal roles in different stages of both 
embryonic and adult neurogenesis, being involved in the regulation of NSCs proliferation, fate 
specification and differentiation. These mechanisms are now becoming to be recognized as 
fundamental for the balanced production of new neuronal and glial cells needed for the homeostatic 
brain function (Mateus-Pinheiro et al. 2011). Cumulative evidence now suggests that epigenetic 
dysregulation also plays an important part in neurodegenerative disorders, and more interestingly, in 
psychiatric disorders (Yao et al. 2016). It is possible to say that epigenetic mechanisms are becoming 
gradually accepted to play dynamic roles in adult neurogenesis, and actually in a recent study from 
Amador-Arjona and colleagues (Amador-Arjona et al. 2015) Sox2 transcription factor was proposed to 
set a permissive epigenetic state in NSCs, enabling in this way the neuronal differentiation under 
neurogenic cue.  
 Having in mind the cumulative evidences of epigenetic modifications in the transcriptional 
sequence underlying adult glutamatergic neurogenesis, and the crucial role of AP2γ in this process we 
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decided to perform a broad analysis of DNA methylation and demethylation – two well-known epigenetic 
mechanisms that play important roles in the adult glutamatergic neurogenic process. Although we still 
did not obtain a clear interpretation of how deficits in AP2γ impact on the epigenetic regulation of adult 
glutamatergic neurogenesis in basal conditions, it was possible to observe alterations in the uCMS 
AP2γ+/- mice.  
  In this thesis, we decided to measure the expression levels of different enzymes involved in the 
methylation and demethylation of DNA. No differences were observed in the methylation enzymes in WT 
and AP2γ+/- animals both in basal and uCMS conditions. We measured the activity of DNMT3a and 
DNMT3b which are largely responsible for the de novo methylation, a process highly important for 
embryogenesis, neural development and the establishment of methylation patterns (Montalban-Loro et 
al. 2015). However, there is another type of methylation reaction, responsible to copy the existing 
methylation patterns, promoted by DNMT1, which we still did not assess. This enzyme is abundantly 
expressed in the embryonic, perinatal and adult CNS in both dividing NSCs and mature neurons, thus it 
is highly relevant to assess in the near future if DNMT1 is affected by the reduced expression of AP2γ. 
Unlike DNA methylation, when we assessed the epigenetic demethylation process we found differences 
between AP2γ+/- control and uCMS groups in the dorsal DG. We measured the activity of the TET family 
of enzymes which are largely responsible for the demethylation process promoting the removal of the 
methyl mark and leaving in this way the gene in a more activated state (Maeder et al. 2013). We did 
obtain a similar pattern among all three TET enzymes (TET1, TET2, TET3) in the dorsal DG, presenting 
a reduced expression after uCMS exposure. Furthermore, in the ventral DG we only found the same 
pattern of expression for the TET1 enzyme.  
These results suggest a reduction in the demethylation process in the AP2γ+/- chronic stressed 
animals, which can be related with the cognitive alterations that we did observe in the constitutive AP2γ 
KO animal model. However, further studies are required to understand which genes have an altered 
demethylated process, perceive if its function are related to neuroplasticity, and if indeed an altered 
epigenetic mechanism, induced by chronic stress exposure, in adult hippocampal neurogenesis can 
lead to significant behavioral adaptations. Moreover, we need to understand how is AP2γ being 
modulated by the demethylation process, if its expression is increasing or decreasing by this 
modulatory action, and how it rebounds in other transcription factors involved in the glutamatergic 
neurogenic process, such as Tbr2, which is highly influenced by the AP2γ (Mateus-Pinheiro et al. 
2016).  
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 The techniques used in this thesis to analyze these specific epigenetic mechanisms gave only a 
broad analysis, allowing to explore if indeed the reduced expression of AP2γ could cause epigenetic 
alterations in the hippocampal neurogenic niche. In the future, and to perform a more specific analysis 
it would be interesting to use different techniques such as DNA bisulfite conversion which allows the 
evaluation of the methylation and demethylation status of individual CpG dinucleotides in the genomic 
DNA, understanding at the same time which genes are being methylated or demethylated in depression 
(Booth et al. 2013). 
 
5.5. AP2γ transcription factor – An integrated perspective  
 
The work developed and presented here was designed to further explore the impact of the 
transcription factor AP2γ in brain neurophysiology and behavior during development and at adult stages 
both in basal and depressive-like conditions. Using two animal models with different mechanical 
targeted AP2γ deletion, we were able to better understand some of the contributions of this 
transcription factor in varied brain processes, from the developmental period until adulthood. One of the 
best characterized function of the AP2γ transcription factor, shown by previous studies of the group, is 
its involvement in the transcriptional network that underlies glutamatergic neurogenesis during 
embryonic development, which integrates several transcription factors sequentially expressed 
(Sox2àPax6àNgn2à Tbr2àNeuroDàTbr1). AP2γ participates in this transcriptional network that 
hallmarks embryonic glutamatergic neurogenesis acting as a downstream target of Pax6, with 
modulatory effects upon basal progenitors such as Tbr2 (Pinto et al. 2009). Interestingly, it was found 
that during adult glutamatergic neurogenesis, neurons recapitulate this transcriptional sequence that 
hallmarks the embryonic glutamatergic neurogenesis in the developing cerebral cortex (Brill et al. 
2009). As such, this transcriptional sequence is maintained postnatally, and actually, more recently we 
were able to identify the presence of AP2γ in the adult hippocampal DG, both in Tbr2-positive 
glutamatergic progenitor cells and neuroblasts. We further revealed that AP2γ is also a positive 
regulator of adult glutamatergic neurogenesis in the adult hippocampal DG, as its overexpression 
increments the generation of new neurons in this region and its deletion, both in vivo and in vitro, 
results in marked reduction of the neuroblasts population (Mateus-Pinheiro et al. 2016). 
 Taking in consideration these previous findings of the group regarding the AP2γ modulatory 
effect of embryonic and adult glutamatergic neurogenesis, we wanted to discriminate if the molecular 
and behavioral deficits seen in the adult constitutive AP2γ KO mice were indeed an adult response or if 
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there is already an impact of AP2γ reduction on post-natal development and on juvenile stages. We also 
wanted to investigate the potential role of AP2γ as a key neurogenesis modulator in the 
neuropathological context of depression, since in this disorder, hippocampal glutamatergic 
neurogenesis is highly affected. To do so, we used two animals models for AP2γ deletion to understand 
the impact of AP2γ in depression in two different perspectives. By using the constitutive AP2γ KO 
model, we intended to understand if the deletion of one allele of AP2γ since embryonic development 
could lead to a predisposition to deficits in the three behavioral dimensions affected by depression, 
since hippocampal glutamatergic neurogenesis is impaired in the AP2γ+/- animals. Through the 
conditional AP2γ KO mice, in which the homozygous deletion of the gene is only induced at adult 
stages prior to the uCMS protocol, we were able to better elucidate the role of this transcription factor 
specifically in adult hippocampal neurogenesis both in basal and depressive-like conditions, without the 
contribution of putative compensatory mechanisms that had eventually emerged since early 
development.  
 We observed in the basal conditions results presented in this thesis, molecular deficits in the 
constitutive AP2γ+/- animals since juvenile development until adulthood, which were largely associated 
with the altered behavioral phenotypes, namely anxiety and cognitive impairments, obtained both at 
juvenile and adult stages. However, if we had only used this constitutive KO animal model, it would not 
have been possible to completely understand if the results observed at the moment of testing were 
indeed an alteration of the reduced expression of AP2γ, or if there were putative compensatory 
mechanisms intervening in the analysis. Combining the evidences from both constitutive and 
conditional AP2γ animals models we were able to better perceive how is this transcription factor 
modulating post-natal hippocampal neurogenesis, and its repercussions in both basal and uCMS 
conditions. Between the constitutive and conditional KO animals two major differences were observed: 
in behavioral tests associated to cognition, and in the expression of the different transcription factors 
involved in the glutamatergic neurons formation in the adult DG. When analyzing the cognitive 
dimension of the constitutive animal, and we compare it with the expression profiles obtained by the 
western blot, it is possible to perceive that there is some sort of compensatory mechanism in the AP2γ+/- 
mice, bolstering the expression of Sox2, Pax6 and Tbr2, ameliorating in this way the deleterious effects 
induced by chronic stress. But when we analyzed the same cognitive dimensions in the chronically 
stressed conditional cAP2γ-/- animals, we did not obtain the same cognitive phenotype, nor the 
bolstering of transcription factors involved in the glutamatergic neurogenic process. Thus, the 
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amelioration of cognitive domains observed in the constitutive uCMS AP2γ+/- animals, seem to be 
determined during the development period. 
 Regarding the anxiety phenotype, we did obtain similar patterns in both constitutive and 
conditional animal models, showing both AP2γ KO (AP2γ+/- and cAP2γ-/-) control groups a higher anxiety 
rate in the OF test, but no differences after uCMS exposure. We also assessed the anxious behavior at 
juvenile ages, showing once again the constitutive AP2γ+/- animals a more anxious-like behavior when 
compared to the WT control group, in the OF test. Thus, the compensatory mechanisms observed in 
the neurogenic transcripts in the constitutive model are not influencing the anxiety dimension, since 
there is no amelioration of the anxious-phenotype in the AP2γ+/- uCMS group. Moreover, when we 
analyzed epigenetic mechanisms in the constitutive model, the most altered area was the dorsal DG 
which is largely associated with the cognitive dimension (Fanselow and Dong 2010), being the ventral 
area (more related to the emotional dimension) less affected by these alterations. Although it is quite 
early to speculate how AP2γ modulates the epigenetic regulators of the neurogenic process, it is 
already noticeable that demethylation of some genes is occurring after chronic stress exposure. 
However, further studies are required to perceive if these alterations in the constitutive model lead to 
some functional impact. 
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6. CONCLUDING REMARKS 
In the past decades, a large effort has been made to unravel the complex pathological basis 
that underlies several neuropsychiatric disorders in which adult hippocampal glutamatergic 
neurogenesis is impaired, such as major depression. The view of adult hippocampal neurogenesis as a 
causative neurobiological mechanism of depression has been supported by several reports, showing the 
high comorbidity between the precipitation of depressive symptomatology and the reduction of 
hippocampal proliferation. Finding a molecule with an important modulatory action in the adult 
hippocampal neurogenic process is, in the present context, of the outmost importance in order to revert 
the pathological effects upon adult neurogenesis, observed in depression. It can be stated that the work 
performed and included in this thesis provided important insights on the potential of AP2γ as a 
promising candidate to mediate such action. In fact, the transcription factor AP2γ was proved to be 
actively involved in the promotion of post-natal neurogenesis in the hippocampal DG neurogenic niche. 
Furthermore, in this thesis, we observed that reduced levels of AP2γ since embryonic development 
already impacted juvenile behavior and impaired neuronal proliferation at this stage of development and 
maturity, specifically causing a more anxious-like phenotype and decreased proliferation of immature 
neurons. Moreover, we submitted both constitutive and conditional animals to an unpredictable chronic 
mild stress protocol, and the behavioral profile revealed that the reduced expression of AP2γ produced 
significant deficits in cortical-dependent cognitive tasks, which is likely a consequence of cortical 
developmental deficits. However, this deletion since embryonic development proved to be beneficial for 
hippocampal dependent cognitive functions, namely working and spatial memory, possibly due to a 
compensatory increase of different transcripts important for adult glutamatergic neurogenesis. This 
compensatory mechanism is further supported by the fact that these transcripts were normally 
expressed in the DG of conditional KO mice after chronic stress exposure.  
 Together, these results further support the involvement of AP2γ in the adult glutamatergic 
neurogenic process, and that it may be a strong candidate to be used as a therapeutical tool in future 
therapies directed to the modulation of the neurogenic niche, mostly in patients with cognitive deficits. 
However, further analyses are needed to elucidate what is the functional role of this transcription factor 
in the context of depressive, and to fully understand the different mechanisms by which AP2γ is 
exerting its modulatory actions. 
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8. ANNEXES 
8.1. Supplementary figures 
 
 
 
 
 
 
 
 
 
 
Supplementary figure 1:  Percentage of weight gain in the AP2γ constitutive KO animal model throughout 
the 6 weeks of uCMS protocol, divided by individual groups. 
 During the uCMS protocol, we controlled the body weight in order to understand if the chronic stress exposure was inducing 
alterations in the animals exposed to it. It was observable that the uCMS was indeed inducing highly different directions 
regarding the percentage weight gain/loss, since the the control groups were gaining and maintaining the weight gain, and 
the uCMS exposed groups lost and maintained the weight loss. However, no differences were found between WT and AP2γ+/- 
groups, proving that there are no differences between the genotypes concerning to eating patterns. (Controls: nWT= 8, nAP2γ+/-= 
7 ; uCMS: nWT= 8, nAP2γ+/-=7; Data presented as mean ± SEM; ****p<0.0001). 
 
Supplementary table 1: Percentage of weight gain in the AP2γ constitutive KO animal model throughout the 6 weeks of 
uCMS protocol, divided by individual groups. Data presented as mean ± SEM. In grey shading are the tests were it was observable 
differences between the variables.  
 
 
 
 
Test 
Control uCMS Statistical test, 
significance, effect size WT AP2γ+/- WT AP2γ+/- 
Weight 
Week 1 -1.06 ± 0.44 -3.02 ± 0.76 -7.48 ± 0.52 -7.83 ± 0.49 
F(1,24)=1.75, p< 0.0001, 
η2partial= 0.55 
Week 2 2.28 ± 1.39 0.53 ± 0.79 -3.63 ± 1.05 -5.60 ±1.08 
Week 3 7.28 ± 1.86 5.99 ± 1.83 -2.22 ± 2.36 -2.59 ± 1.31 
Week 4 6.54 ± 1.65 3.48 ± 1.57 -3.05 ± 2.52 -4.19 ± 1.51 
Week 5 10.70 ± 1.49 10.13 ± 2.15 2.20 ± 2.70 0.22 ± 1.26 
Week 6 10.88 ± 1.82 10.09 ± 2.02 -1.42 ± 2.49 -3.41 ± 1.6 
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
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Supplementary figure 2:  Percentage of weight gain/loss in the AP2γ conditional KO animal model 
throughout the 6 weeks of uCMS protocol, divided by individual groups. During the uCMS protocol, we controlled 
the body weight in order to understand if the chronic stress exposure was inducing alterations in the animals exposed to it. It 
was observable that the uCMS was indeed inducing highly different directions regarding the percentage weight gain/loss, 
since the the control groups were gaining and maintaining the weight gain, and the uCMS exposed groups lost and 
maintained the weight loss. However, no differences were found between cAP2γ+/+ and        cAP2γ-/-  groups, proving that 
there are no differences between the genotypes concerning to eating patterns. (Controls: n cAP2γ+/+= 12, ncAP2γ-/-=5; uCMS: n 
cAP2γ
+/+=12, nAP2γ-/-=8; Data presented as mean ± SEM; ****p<0.0001]. 
 
Supplementary table 2: Percentage of weight gain in the AP2γ conditional KO animal model throughout the 6 weeks of 
uCMS protocol, divided by individual groups. Data presented as mean ± SEM. In grey shading are the tests were it was observable 
differences between the variables.  
 
 
 
 
Test 
Control uCMS Statistical test, 
significance, effect size cAP2γ+/+ cAP2γ-/- cAP2γ+/+ cAP2γ-/- 
Weight 
Week 1 -0.62 ± 0.62 2.63 ± 1.82 -4.22 ± 0.60 -4.00 ± 1.53 
F(1,36)=3.16, p< 0.0001, 
η2partial= 0.64 
Week 2 2.41 ± 0.81 4.40 ± 2.23 -1.62 ± 0.60 -4.18 ± 1.31 
Week 3 3.01 ± 2.00 6.88 ± 2.87 -3.63 ± 1.31 -5.24 ± 0.97 
Week 4 8.23 ± 1.13 10.27 ± 3.81 -1.54 ± 1.28 -2.02 ± 1.12 
Week 5 8.14 ± 1.10 7.70 ± 3.17 -3.38 ± 1.35 -4.13 ± 1.04 
Week 6 8.89 ± 1.13 5.07 ± 3.64 -0.71 ± 1.31 -0.21 ± 1.25 
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
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